{"id": "Q001", "timestamp_utc": "2025-12-16T06:47:59.815530+00:00", "top_k": 5, "question": "What lifestyle counselling elements should be covered for a newly diagnosed patient with diabetes?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Lifestyle counselling for a newly diagnosed person with diabetes should cover (at minimum):\n\n- **Healthy diet**: principles and importance of a healthy diet; for overweight/obese patients, **lower calorie intake**; **replace saturated fats with unsaturated fats**; ensure **dietary fibre intake** at least equal to general-population recommendations; **avoid added sugars**. (p51)  \n- **Physical activity**: regular physical activity, **adapted to the person’s capabilities**. (p51)  \n- **Avoid tobacco**: counsel to avoid tobacco use. (p50–51)  \n- **Avoid harmful/excess alcohol**: avoid harmful use/excessive use of alcohol. (p50–51)  \n- **Adherence/engagement**: emphasize adherence to recommendations and treatment (including medication adherence as part of overall self-management education). (p51)  \n- **Foot care**: **foot hygiene** and **appropriate footwear**. (p51)  \n- **Ongoing monitoring**: the need for **periodic assessment of metabolic control** and for the **presence/progression of complications**. (p51)", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 51, "text": "51MANAGING  DIABETES\n y Integrated management of \ndiabetes and other diseases \n(see Diabetes and other NCDs,  \npage  55).\nThe effectiveness of diabetes \nmanagement ultimately depends \non people’s compliance with \nrecommendations and treatment. \nPatient education is therefore \nan important component of \ndiabetes management. Patients \nneed to understand the principles \nand importance of a healthy \ndiet, adequate physical activity, \navoidance of tobacco and harmful \nuse of alcohol, adherence to \nmedication, foot hygiene and \nappropriate footwear, and the \nneed for periodic assessment \nof metabolic control and the \npresence or progression of \ncomplications (13).\nINTE rvENTIONS TO P rOMOTE \nHEA lTHIE r EATING AND PH ySICA l \nACTI vIT y\nAll people with diabetes need \ncounselling on healthy diet and \nregular physical activity, adapted \nto their capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calor", "score": 0.5912030692856929}, {"source": "content.pdf", "page": 51, "text": "capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calorie \nintake for overweight and obese \npatients, and replacing saturated \nfats with unsaturated fats (14); \nintake of dietary fibre equal to or \nhigher than that recommended \nfor the general population (15); \nand avoiding added sugars, \ntobacco use and excessive use of \nalcohol (16). Education of patients \nin groups is a cost-effective \nstrategy (13).\nIt has been suspected for some time \nthat energy restriction through a \nvery low-calorie diet can lead to \nthe reduction of symptoms or to \nthe reversal of hyperglycaemia \ntypical of type 2 diabetes – the \nreversal may be maintained so \nlong as weight is not regained (17) \n(see Box 8).\nEnergy restriction through \nbariatric (or metabolic) surgery to \nreduce the size of the stomach is \nnow established as an effective \ntreatment for severe obesity-\nrelated type 2 diabetes, at least \nin communitie", "score": 0.5638540657102196}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.5557018991991157}, {"source": "content.pdf", "page": 42, "text": "42 Pr E vENTING  DIABETES\nrisk for future development of \ntype  2 diabetes. These people \nshould receive (as a minimum) \nrepeat counselling on weight loss, \ndiet, physical activity and smoking.\nWhile type 2 diabetes is potentially \npreventable, the causes and risk \nfactors for type 1 diabetes remain \nunknown and prevention strategies \nhave not yet been successful \n(see Box 5).\n2.3 S uMMA ry\nMuch type 2 diabetes results from \nmodifiable risk factors that can \nbe reduced using a combination \nof approaches at population \nand individual levels. Creating \nsupportive policy, social and \nphysical environments for healthy \nlifestyles is a key aspect of type 2 \ndiabetes prevention. Sustaining \nthe lifestyle changes needed to \nreduce risk requires supportive \nfamily and social networks, as well \nas an enabling food system and \nphysical environment. Healthy \nfood and opportunities for physical \nactivity must be available and \naffordable.\nBOx 5. TOwArDS P rEvENTION O f T yPE 1 DIABETES\nA variety o", "score": 0.5503233769262257}, {"source": "content.pdf", "page": 7, "text": "tical window for intervention to mitigate the risk of obesity and \ntype 2 diabetes later in life.\nNo single policy or intervention can ensure this happens. It calls for a whole-of-government and whole-of-\nsociety approach, in which all sectors systematically consider the health impact of policies in trade, agriculture, \nfinance, transport, education and urban planning – recognizing that health is enhanced or obstructed as a \nresult of policies in these and other areas.\nMANAGING DIABETES\nThe starting point for living well with diabetes is an early diagnosis – the longer a person lives with undiagnosed \nand untreated diabetes, the worse their health outcomes are likely to be. Easy access to basic diagnostics, \nsuch as blood glucose testing, should therefore be available in primary health-care settings. Established \nsystems for referral and back-referral are needed, as patients will need periodic specialist assessment or \ntreatment for complications.\nFor those who are diagnosed with diabe", "score": 0.5438895521764906}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence directly supports listed counselling elements: healthy diet (including lower calories for overweight/obese, replacing saturated with unsaturated fats, fibre, avoiding added sugars), physical activity adapted to capabilities, avoidance of tobacco and harmful/excess alcohol, adherence to medication/recommendations, foot hygiene/appropriate footwear, and periodic assessment of metabolic control/complications (pp50–51). No unsupported additions. Category matches lifestyle management recommendations."}, "judge_error": null}
{"id": "Q002", "timestamp_utc": "2025-12-16T06:48:12.992841+00:00", "top_k": 5, "question": "What dietary patterns are broadly recommended for type 2 diabetes (e.g., calories, fats, fibre, added sugars)?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Broad dietary recommendations for type 2 diabetes (and prevention) include:  \n\n- **Calories/energy:** For **overweight or obese patients**, guidelines agree on a **lower calorie intake** (energy restriction) to support weight loss. Very low-calorie diets may reduce symptoms or reverse hyperglycaemia as long as weight is not regained. (p51)  \n- **Fats:**  \n  - **Limit saturated fat** to **<10% of total energy** (and **<7%** for high-risk groups). (p36)  \n  - **Replace saturated fats with unsaturated fats**, including replacing saturated fatty acids with **polyunsaturated fatty acids**. (p36, p51)  \n- **Fibre:** Aim for **adequate dietary fibre**, at least **20 g/day**, via regular intake of **wholegrains, legumes, fruits, and vegetables**. Guidelines for type 2 diabetes recommend fibre intake **equal to or higher than** that for the general population. (p36, p51)  \n- **Added/free sugars:** WHO **strongly recommends** reducing **free sugars** to **<10% of total energy**, and suggests that reducing to **5%** may provide additional benefits. Guidelines also recommend **avoiding added sugars**. (p36, p51)", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 36, "text": "nd replacing saturated fatty acids with polyunsaturated fatty acids. \nWHO has developed recommendations on healthy diet and physical activity that, if implemented, \ncan reduce an individual’s risk of type 2 diabetes and other NCDs.\nDietary recommendations by WHO and the Food and Agriculture Organization (FAO) for the \nprevention of type 2 diabetes include limiting saturated fatty acid intake to less than 10% of total \nenergy intake (and for high risk groups, less than 7%); and achieving adequate intakes of dietary \nfibre (minimum daily intake of 20 g) through regular consumption of wholegrain cereals, legumes, \nfruits and vegetables (3). WHO is currently updating its guidelines on fat intake and carbohydrate \nintake, which will include recommendations on dietary fibre as well as fruits and vegetables. WHO \nstrongly recommends  reducing the intake of free sugars to less than 10% of total energy intake and \nsuggests that further reduction to 5% could have additional health benefits (4).", "score": 0.6618810874666419}, {"source": "content.pdf", "page": 51, "text": "capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calorie \nintake for overweight and obese \npatients, and replacing saturated \nfats with unsaturated fats (14); \nintake of dietary fibre equal to or \nhigher than that recommended \nfor the general population (15); \nand avoiding added sugars, \ntobacco use and excessive use of \nalcohol (16). Education of patients \nin groups is a cost-effective \nstrategy (13).\nIt has been suspected for some time \nthat energy restriction through a \nvery low-calorie diet can lead to \nthe reduction of symptoms or to \nthe reversal of hyperglycaemia \ntypical of type 2 diabetes – the \nreversal may be maintained so \nlong as weight is not regained (17) \n(see Box 8).\nEnergy restriction through \nbariatric (or metabolic) surgery to \nreduce the size of the stomach is \nnow established as an effective \ntreatment for severe obesity-\nrelated type 2 diabetes, at least \nin communitie", "score": 0.6592602761239363}, {"source": "content.pdf", "page": 18, "text": "et. \n2015;386(10010):2287–323.\n5. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist circumference \nand waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiologic Reviews. \n2007;29:115 –28.\n6. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:(9712)408–418.\n7. Ley SH, Hamdy, O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary \ncomponents and nutritional strategies. Lancet. 2014;383(9933):1999–2007.\n8. Fats and fatty acids in human nutrition: report of an expert consultation. FAO Food and Nutrition Paper \n91. Rome: Food and Agriculture Organization of the United Nations; 2010.\n9. Diet, nutrition and the prevention of chronic diseases: report of a Joint WHO/FAO Expert Consultation. \nWHO Technical Report Series, No. 916. Geneva: World Health Organization; 2003.\n10. WHO Guideline: sugars intake in adults and children. Geneva: World Health Organization; 2015.\n11. Te Morenga L, Mallard S, Mann", "score": 0.6027845306366381}, {"source": "content.pdf", "page": 12, "text": "populations  (5). \nPopulations in South-East Asia, \nfor example, develop diabetes at a \nlower level of BMI than populations \nof European origin (6).\nSeveral dietary practices are linked \nto unhealthy body weight and/or \ntype  2 diabetes risk, including \nhigh intake of saturated fatty \nacids, high total fat intake and \ninadequate consumption of dietary \nfibre (7, 8, 9). High intake of sugar-\nsweetened beverages, which \ncontain considerable amounts \nof free sugars,  1 increases the \nlikelihood of being overweight \nor obese, particularly among \nchildren (10, 11). Recent evidence \nfurther suggests an association \nbetween high consumption of \nsugar-sweetened beverages and \nincreased risk of type  2 diabetes \n(7, 12, 13, 14).\nEarly childhood nutrition affects \nthe risk of type 2 diabetes later in \nlife. Factors that appear to increase \nrisk include poor fetal growth, \nlow birth weight (particularly if \nfollowed by rapid postnatal catch-\nup growth) and high birth weight \n(15, 16, 17, 18, 19,", "score": 0.5534160344945791}, {"source": "content.pdf", "page": 63, "text": "real-time medication \nmonitoring with short message service (SMS) reminders for missed doses on the refill adherence of \npeople with Type 2 diabetes: evidence from a randomised controlled trial. Diabetic Medicine: 2014, \n31(7), 821-828.\n13. Implementation tools: Package of Essential Noncommunicable (PEN) Disease Interventions for Primary \nHealth Care in Low-Resource Settings. Geneva: World Health Organization; 2013.\n14. Fats and fatty acids in human nutrition: report of an expert consultation. FAO Food and Nutrition Paper \n91. Rome: Food and Agriculture Organization of the United Nations; 2010.\n15. Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary \ncomponents and nutritional strategies. Lancet. 2014;383:(9933)1999–2007.\n16. Guideline: Sugars intake for adults and children. Geneva: World Health Organization; 2015.\n17. Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:(4)1047–1055.\n18. Maggard-Gibbons M, Maglione M, Livhits", "score": 0.5523049423736813}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 5, "notes": "Retrieval is relevant: evidence supports lower calorie intake for overweight/obese, replacing saturated with unsaturated fats, fibre minimum 20 g/day and sources, and avoiding added sugars. However, answer adds specific saturated fat thresholds (<10% and <7%) grounded in evidence for prevention (p36) but not explicitly stated as T2D management; still broadly aligned. It also introduces WHO free sugars <10% and 5% additional benefits, which are not present in provided evidence, reducing groundedness."}, "judge_error": null}
{"id": "Q003", "timestamp_utc": "2025-12-16T06:48:22.714914+00:00", "top_k": 5, "question": "What physical activity approach is recommended (aerobic vs resistance, frequency conceptually) for adults with type 2 diabetes?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "For adults with type 2 diabetes, physical activity should be **regular** and should **ideally combine aerobic exercise with resistance training**, as this supports insulin action and blood glucose control and can reduce cardiovascular risk factors. (p51)", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 51, "text": "have a beneficial effect on insulin \naction, blood glucose control \nand metabolic abnormalities \nassociated with diabetes. Physical \nactivity can also be beneficial in \nreducing cardiovascular disease \nrisk factors. Activity should be \nregular and ideally combine \naerobic exercise with resistance \ntraining (19).\nBlood glucose control \nis important in \npreventing and slowing \nthe progression of \ncomplications", "score": 0.6016559182597723}, {"source": "content.pdf", "page": 36, "text": "36 Pr E vENTING  DIABETES\nphysical activity in the population \nwill help reduce the occurrence of \nobesity and type 2 diabetes, and \nwill accrue additional benefits by \nreducing complications among \npeople with all types of diabetes \nand glucose intolerance. WHO’s \nrecommendations for healthy diet \nand physical activity relevant to \ndiabetes are summarized in Box 2.\nPopulation-level interventions to \nreduce tobacco use may contribute \nto prevention of type 2 diabetes, \ngiven emerging evidence of a \nlink between smoking and type 2 \ndiabetes risk. Active tobacco use \nBOx 2. HEA lTHy DIET AND PH ySICA l ACTI vIT y\nAdults can reduce their risk of type 2 diabetes and improve insulin sensitivity and glucose uptake \nthrough regular and adequate levels of physical activity and healthy diets that include sufficient \nconsumption of dietary fibre, and replacing saturated fatty acids with polyunsaturated fatty acids. \nWHO has developed recommendations on healthy diet and physical activity that, if", "score": 0.5599525744777074}, {"source": "content.pdf", "page": 40, "text": "activity and \nlead to the loss of excess body \nweight can prevent type 2 diabetes \nin people with impaired glucose \ntolerance, with or without impaired \nfasting glucose. For example, the \nDiabetes Prevention Program \n(DPP) in the USA (30), the Finnish \nDiabetes Prevention Study (DPS) \n(31) and the Chinese Da Qing Study \nshowed that active intervention, \nlasting 2 to 6 years, could have \nextended benefits for glycaemic \nand cardiovascular outcomes that \nlast for 10 to 20 years (32).\nSeveral pharmacological  \ninterventions (for example, \nmetformin and acarbose) have \nalso been shown to prevent or \ndelay type 2 diabetes but, in the \nmajority of studies, this is not as \neffective as changes in diet and \nphysical activity, and the effect \ndissipates after discontinuation \nof the medication (33, 34) .\nKnowledge gained from these \nproof-of-concept studies confirms \nthat type 2 diabetes can be \ndelayed or prevented, but turning \nthis knowledge into large-\nscale impact brings significant \nchall", "score": 0.5294778221105827}, {"source": "content.pdf", "page": 63, "text": "tion; 2015.\n17. Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:(4)1047–1055.\n18. Maggard-Gibbons M, Maglione M, Livhits M, Ewing B, Maher AR, Hu J, et al. Bariatric surgery for \nweight loss and glycemic control in non-morbidly obese adults with diabetes: a systematic review. \nJournal of the American Medical Association. 2013;309:(21)2250–2261.\n19. Hayes C, Kriska A. Role of physical activity in diabetes management and prevention. Journal of the \nAmerican Dietetic Association. 2008;108:(4 Suppl 1)S19–S23.", "score": 0.5186833188912728}, {"source": "content.pdf", "page": 79, "text": "79CONC lu SIONS  AND  r ECOMMENDATIONS\n y Create supportive built and social environments for physical activity – transport and urban planning policy \nmeasures can facilitate access to safe, affordable opportunities for physical activity. Point-of-decision prompts \ncan encourage more active transport – to use stairs versus a lift, for example.\n y Maximize impact with multicomponent programmes involving policy changes, settings-based interventions, \nmass media campaigns and education. Prioritize highly vulnerable and/or disadvantaged groups.\nIn addition to measures to promote healthy diet and physical activity, reducing exposure to tobacco will \nreduce the complications of diabetes and may lead to reductions in type 2 diabetes. Tobacco use can be \nreduced through implementation of comprehensive tobacco control measures in line with WHO’s Framework \nConvention on Tobacco Control.\n4. ST rENGTHEN AND Or IENT HEA lTH S ySTEMS TO ADD rESS DIABETES\nImprovements in diabetes management will red", "score": 0.5092541747099375}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence on p51 explicitly states activity should be regular and ideally combine aerobic with resistance training, with benefits on insulin action, glucose control, and CVD risk factors. Answer accurately reflects this. No specific frequency beyond 'regular' is supported, and the answer does not invent details."}, "judge_error": null}
{"id": "Q004", "timestamp_utc": "2025-12-16T06:48:31.512675+00:00", "top_k": 5, "question": "Should patients with diabetes be counselled about tobacco and alcohol use?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Yes. Patient education and counselling for people with diabetes should include **avoidance of tobacco** and **harmful/excessive alcohol use** as part of healthy lifestyle management (p51). National diabetes management guidelines/protocols are recommended to cover lifestyle interventions including **avoidance of tobacco use and harmful use of alcohol** (p50).", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 51, "text": "51MANAGING  DIABETES\n y Integrated management of \ndiabetes and other diseases \n(see Diabetes and other NCDs,  \npage  55).\nThe effectiveness of diabetes \nmanagement ultimately depends \non people’s compliance with \nrecommendations and treatment. \nPatient education is therefore \nan important component of \ndiabetes management. Patients \nneed to understand the principles \nand importance of a healthy \ndiet, adequate physical activity, \navoidance of tobacco and harmful \nuse of alcohol, adherence to \nmedication, foot hygiene and \nappropriate footwear, and the \nneed for periodic assessment \nof metabolic control and the \npresence or progression of \ncomplications (13).\nINTE rvENTIONS TO P rOMOTE \nHEA lTHIE r EATING AND PH ySICA l \nACTI vIT y\nAll people with diabetes need \ncounselling on healthy diet and \nregular physical activity, adapted \nto their capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calor", "score": 0.5401128507198414}, {"source": "content.pdf", "page": 36, "text": "include \nbalance and muscle strengthening activity tailored to their ability and circumstances.\ncan be reduced through a set of \nlegislative, regulatory, fiscal and \neducational measures including \ngraphic warnings on cigarette \npacks, bans on advertising \nand promotion, raising taxes \non tobacco and implementing \nmass media campaigns (6). WHO \nMember States have committed \nto these and other actions through \nWHO’s Framework Convention on \nTobacco Control, which entered \ninto force in 2005. Reducing \npopulation exposure to tobacco \nmay also reduce diabetes-related \ncomplications, in part through \nreducing cardiovascular risk.", "score": 0.5334111351621479}, {"source": "content.pdf", "page": 51, "text": "capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calorie \nintake for overweight and obese \npatients, and replacing saturated \nfats with unsaturated fats (14); \nintake of dietary fibre equal to or \nhigher than that recommended \nfor the general population (15); \nand avoiding added sugars, \ntobacco use and excessive use of \nalcohol (16). Education of patients \nin groups is a cost-effective \nstrategy (13).\nIt has been suspected for some time \nthat energy restriction through a \nvery low-calorie diet can lead to \nthe reduction of symptoms or to \nthe reversal of hyperglycaemia \ntypical of type 2 diabetes – the \nreversal may be maintained so \nlong as weight is not regained (17) \n(see Box 8).\nEnergy restriction through \nbariatric (or metabolic) surgery to \nreduce the size of the stomach is \nnow established as an effective \ntreatment for severe obesity-\nrelated type 2 diabetes, at least \nin communitie", "score": 0.4978391405047343}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.4946204066242226}, {"source": "content.pdf", "page": 42, "text": "42 Pr E vENTING  DIABETES\nrisk for future development of \ntype  2 diabetes. These people \nshould receive (as a minimum) \nrepeat counselling on weight loss, \ndiet, physical activity and smoking.\nWhile type 2 diabetes is potentially \npreventable, the causes and risk \nfactors for type 1 diabetes remain \nunknown and prevention strategies \nhave not yet been successful \n(see Box 5).\n2.3 S uMMA ry\nMuch type 2 diabetes results from \nmodifiable risk factors that can \nbe reduced using a combination \nof approaches at population \nand individual levels. Creating \nsupportive policy, social and \nphysical environments for healthy \nlifestyles is a key aspect of type 2 \ndiabetes prevention. Sustaining \nthe lifestyle changes needed to \nreduce risk requires supportive \nfamily and social networks, as well \nas an enabling food system and \nphysical environment. Healthy \nfood and opportunities for physical \nactivity must be available and \naffordable.\nBOx 5. TOwArDS P rEvENTION O f T yPE 1 DIABETES\nA variety o", "score": 0.4938299048648922}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence explicitly states patient education should include avoidance of tobacco and harmful alcohol use (p51) and that guidelines should cover lifestyle interventions including avoidance of tobacco and harmful alcohol (p50). Answer accurately reflects this without adding unsupported claims. Categorized correctly as lifestyle management recommendations."}, "judge_error": null}
{"id": "Q005", "timestamp_utc": "2025-12-16T06:48:40.738282+00:00", "top_k": 5, "question": "What role does structured patient education or diabetes self-management education play in diabetes management?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Structured patient education/diabetes self-management education is a **core component** of diabetes management because outcomes “ultimately depend on people’s compliance with recommendations and treatment,” requiring **active patient participation** (p51, p61). It helps patients understand and carry out key self-care behaviors—**healthy diet, physical activity, avoiding tobacco and harmful alcohol use, medication adherence, foot hygiene/appropriate footwear, and the need for periodic assessment of metabolic control and complications** (p51). \n\nAt the primary care level, diabetes outcomes can be improved with “basic interventions involving medication, **health education and counselling**, and consistent follow-up,” delivered as part of systematic, ongoing care (p49). Education delivered **in groups** is noted as a **cost-effective strategy** (p51).", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 51, "text": "51MANAGING  DIABETES\n y Integrated management of \ndiabetes and other diseases \n(see Diabetes and other NCDs,  \npage  55).\nThe effectiveness of diabetes \nmanagement ultimately depends \non people’s compliance with \nrecommendations and treatment. \nPatient education is therefore \nan important component of \ndiabetes management. Patients \nneed to understand the principles \nand importance of a healthy \ndiet, adequate physical activity, \navoidance of tobacco and harmful \nuse of alcohol, adherence to \nmedication, foot hygiene and \nappropriate footwear, and the \nneed for periodic assessment \nof metabolic control and the \npresence or progression of \ncomplications (13).\nINTE rvENTIONS TO P rOMOTE \nHEA lTHIE r EATING AND PH ySICA l \nACTI vIT y\nAll people with diabetes need \ncounselling on healthy diet and \nregular physical activity, adapted \nto their capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calor", "score": 0.5379679878877525}, {"source": "content.pdf", "page": 61, "text": "ell-\ndefined, fairly easy to diagnose, \nand common; and because optimal \nmanagement of diabetes requires \nthe coordinated involvement of a \nvariety of health-care providers \nat multiple levels of the health-\ncare system, ongoing monitoring, \naccess to essential medicines \nand technologies, and active \npatient participation. Solutions for \nimproving diabetes management \ncould therefore provide lessons for \nmanagement of other NCDs.\nThe costs of diabetes management \nare high but they are likely to be \ndwarfed by the economic costs of \npoor or non-existent care in the \nDiabetes management \ncan be strengthened \nthrough  \nimplementation \nof standards and \nprotocols, even in  \nlow-resource settings", "score": 0.5026236703436384}, {"source": "content.pdf", "page": 79, "text": "ramework \nConvention on Tobacco Control.\n4. ST rENGTHEN AND Or IENT HEA lTH S ySTEMS TO ADD rESS DIABETES\nImprovements in diabetes management will reduce rates of complications, ease pressure on health systems \nand improve quality of life for people living with diabetes.\nThe core components of diabetes management include diagnosis; health education and counselling to promote \nhealthy choices and self-care; medications in some cases; screening and treatment of complications; and \nconsistent follow-up. Provision of these building blocks of care in a primary health-care setting requires adequate \nhealth infrastructure and planning.\nDiabetes management should be part of national NCD management and be incorporated into the package \nof essential services included in universal health coverage. Recommended actions to strengthen diabetes \nmanagement include the following steps.\n y Adapt and implement a primary health-care package for the diagnosis and effective management of all \ntypes of diabe", "score": 0.49946319267258343}, {"source": "content.pdf", "page": 49, "text": "49MANAGING  DIABETES\n3.2 MANAGEMENT Of  DIABETES – \nCOr E COMPONENTS\nPeople with diabetes require \naccess to systematic, ongoing and \norganized care delivered by a team \nof skilled health-care providers. \nOutcomes can be improved at \nthe primary care level with basic \ninterventions involving medication, \nhealth education and counselling, \nand consistent follow-up. This \nsystematic care should include \na periodic review of metabolic \ncontrol and complications, an \nagreed and continually updated \ndiabetes care plan, and access \nto person-centred care provided \nby a multidisciplinary team. New \ntechnologies such as telemedicine \nand mobile phone technology are \nalso increasingly being used and \nhave the potential to reach remote \nareas (see Box 7).\nWhile most treatment and tests \ncan be done at primary care level, \nperiodic referral for specialist \ncare is required, for example, for \ncomprehensive eye examinations, \nlaser and surgical treatment of eye \ncomplications, complex kidney \nfunct", "score": 0.4975984661531602}, {"source": "content.pdf", "page": 51, "text": "capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calorie \nintake for overweight and obese \npatients, and replacing saturated \nfats with unsaturated fats (14); \nintake of dietary fibre equal to or \nhigher than that recommended \nfor the general population (15); \nand avoiding added sugars, \ntobacco use and excessive use of \nalcohol (16). Education of patients \nin groups is a cost-effective \nstrategy (13).\nIt has been suspected for some time \nthat energy restriction through a \nvery low-calorie diet can lead to \nthe reduction of symptoms or to \nthe reversal of hyperglycaemia \ntypical of type 2 diabetes – the \nreversal may be maintained so \nlong as weight is not regained (17) \n(see Box 8).\nEnergy restriction through \nbariatric (or metabolic) surgery to \nreduce the size of the stomach is \nnow established as an effective \ntreatment for severe obesity-\nrelated type 2 diabetes, at least \nin communitie", "score": 0.49189864029255476}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence directly supports the role of patient education as an important/core component: management depends on compliance and active participation (p51, p61). It specifies education content (diet, physical activity, tobacco/alcohol avoidance, medication adherence, foot care, periodic assessment) (p51) and notes primary-care improvements via health education/counselling and follow-up (p49, p79). Group education as cost-effective is supported (p51). Categories align with lifestyle management recommendations."}, "judge_error": null}
{"id": "Q006", "timestamp_utc": "2025-12-16T06:48:51.649705+00:00", "top_k": 5, "question": "For overweight or obese adults with type 2 diabetes, what weight-related advice is emphasized?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "For overweight or obese adults with type 2 diabetes, weight-related advice emphasizes **reducing calorie intake (energy restriction)** to promote weight loss and improve glycaemia (p51). The evidence notes that **very low-calorie diets** can reduce symptoms or even reverse hyperglycaemia, and this benefit **may be maintained as long as weight is not regained** (p51).", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 51, "text": "capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calorie \nintake for overweight and obese \npatients, and replacing saturated \nfats with unsaturated fats (14); \nintake of dietary fibre equal to or \nhigher than that recommended \nfor the general population (15); \nand avoiding added sugars, \ntobacco use and excessive use of \nalcohol (16). Education of patients \nin groups is a cost-effective \nstrategy (13).\nIt has been suspected for some time \nthat energy restriction through a \nvery low-calorie diet can lead to \nthe reduction of symptoms or to \nthe reversal of hyperglycaemia \ntypical of type 2 diabetes – the \nreversal may be maintained so \nlong as weight is not regained (17) \n(see Box 8).\nEnergy restriction through \nbariatric (or metabolic) surgery to \nreduce the size of the stomach is \nnow established as an effective \ntreatment for severe obesity-\nrelated type 2 diabetes, at least \nin communitie", "score": 0.6275504486113995}, {"source": "content.pdf", "page": 51, "text": "to \nreduce the size of the stomach is \nnow established as an effective \ntreatment for severe obesity-\nrelated type 2 diabetes, at least \nin communities and health-care \ncontexts where necessary resources \nare available. The disappearance \nof diabetes that occurs in a large \nnumber of diabetic patients after \nbariatric surgery often happens \nwithin days of surgery, similar \nto that which occurs at the \nstart of a very low-calorie diet, \nbefore weight loss – indicating \nthe possible role of gut-related \nhormones in glucose metabolism. \nDepending on the surgical \ntechnique, reduction in excess \nbody weight ranges from 54–72% \n(18) . However, many health-\ncare settings lack the required \nresources for this type of surgery, \nmaking such treatment accessible \nto only a few.\nIn addition to general health \nbenefits, physical activity appears \nto have a beneficial effect on insulin \naction, blood glucose control \nand metabolic abnormalities \nassociated with diabetes. Physical \nactivity can also", "score": 0.5753042874793135}, {"source": "content.pdf", "page": 63, "text": "tion; 2015.\n17. Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:(4)1047–1055.\n18. Maggard-Gibbons M, Maglione M, Livhits M, Ewing B, Maher AR, Hu J, et al. Bariatric surgery for \nweight loss and glycemic control in non-morbidly obese adults with diabetes: a systematic review. \nJournal of the American Medical Association. 2013;309:(21)2250–2261.\n19. Hayes C, Kriska A. Role of physical activity in diabetes management and prevention. Journal of the \nAmerican Dietetic Association. 2008;108:(4 Suppl 1)S19–S23.", "score": 0.5610397556321874}, {"source": "content.pdf", "page": 35, "text": "sing \nkEy MESSAGES\nType 2 diabetes is largely preventable.\nMultisectoral, population-based approaches are needed to reduce the prevalence \nof modifiable diabetes risk factors – such as overweight, obesity, physical \ninactivity and unhealthy diet – in the general population.\nA combination of fiscal policies, legislation, changes to the environment and \nraising awareness of health risks works best for promoting healthier diets and \nphysical activity.\nDiabetes can be delayed or prevented in people who are overweight and have \nimpaired glucose tolerance (IGT). Diet and physical activity interventions are more \neffective than medication.", "score": 0.5399104809034834}, {"source": "content.pdf", "page": 40, "text": "activity and \nlead to the loss of excess body \nweight can prevent type 2 diabetes \nin people with impaired glucose \ntolerance, with or without impaired \nfasting glucose. For example, the \nDiabetes Prevention Program \n(DPP) in the USA (30), the Finnish \nDiabetes Prevention Study (DPS) \n(31) and the Chinese Da Qing Study \nshowed that active intervention, \nlasting 2 to 6 years, could have \nextended benefits for glycaemic \nand cardiovascular outcomes that \nlast for 10 to 20 years (32).\nSeveral pharmacological  \ninterventions (for example, \nmetformin and acarbose) have \nalso been shown to prevent or \ndelay type 2 diabetes but, in the \nmajority of studies, this is not as \neffective as changes in diet and \nphysical activity, and the effect \ndissipates after discontinuation \nof the medication (33, 34) .\nKnowledge gained from these \nproof-of-concept studies confirms \nthat type 2 diabetes can be \ndelayed or prevented, but turning \nthis knowledge into large-\nscale impact brings significant \nchall", "score": 0.5384081199500201}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 5, "notes": "Evidence (p51) supports emphasizing lower calorie intake/energy restriction for overweight/obese T2D and notes very low-calorie diets may reduce symptoms or reverse hyperglycaemia. However, the answer’s claim that benefit is maintained “as long as weight is not regained” is not present in the provided evidence, reducing groundedness."}, "judge_error": null}
{"id": "Q007", "timestamp_utc": "2025-12-16T06:49:00.882189+00:00", "top_k": 5, "question": "Are group education programmes mentioned as effective or cost-effective for diabetes self-management?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Yes. The evidence explicitly states that “Education of patients in groups is a cost-effective strategy” for diabetes management (p51). However, the provided evidence does not specify that group education is *effective* (only cost-effective is directly stated) (p51).", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 51, "text": "capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calorie \nintake for overweight and obese \npatients, and replacing saturated \nfats with unsaturated fats (14); \nintake of dietary fibre equal to or \nhigher than that recommended \nfor the general population (15); \nand avoiding added sugars, \ntobacco use and excessive use of \nalcohol (16). Education of patients \nin groups is a cost-effective \nstrategy (13).\nIt has been suspected for some time \nthat energy restriction through a \nvery low-calorie diet can lead to \nthe reduction of symptoms or to \nthe reversal of hyperglycaemia \ntypical of type 2 diabetes – the \nreversal may be maintained so \nlong as weight is not regained (17) \n(see Box 8).\nEnergy restriction through \nbariatric (or metabolic) surgery to \nreduce the size of the stomach is \nnow established as an effective \ntreatment for severe obesity-\nrelated type 2 diabetes, at least \nin communitie", "score": 0.5318994383261046}, {"source": "content.pdf", "page": 7, "text": "back-referral are needed, as patients will need periodic specialist assessment or \ntreatment for complications.\nFor those who are diagnosed with diabetes, a series of cost-effective interventions can improve their \noutcomes, regardless of what type of diabetes they may have. These interventions include blood glucose \ncontrol, through a combination of diet, physical activity and, if necessary, medication; control of blood \npressure and lipids to reduce cardiovascular risk and other complications; and regular screening for damage \nto the eyes, kidneys and feet, to facilitate early treatment. Diabetes management can be strengthened \nthrough the use of standards and protocols.\nEfforts to improve capacity for diagnosis and treatment of diabetes should occur in the context of integrated \nnoncommunicable disease (NCD) management to yield better outcomes. At a minimum, diabetes and \ncardiovascular disease management can be combined. Integrated management of diabetes and tuberculosis \nand/or HI", "score": 0.5205783599445788}, {"source": "content.pdf", "page": 51, "text": "51MANAGING  DIABETES\n y Integrated management of \ndiabetes and other diseases \n(see Diabetes and other NCDs,  \npage  55).\nThe effectiveness of diabetes \nmanagement ultimately depends \non people’s compliance with \nrecommendations and treatment. \nPatient education is therefore \nan important component of \ndiabetes management. Patients \nneed to understand the principles \nand importance of a healthy \ndiet, adequate physical activity, \navoidance of tobacco and harmful \nuse of alcohol, adherence to \nmedication, foot hygiene and \nappropriate footwear, and the \nneed for periodic assessment \nof metabolic control and the \npresence or progression of \ncomplications (13).\nINTE rvENTIONS TO P rOMOTE \nHEA lTHIE r EATING AND PH ySICA l \nACTI vIT y\nAll people with diabetes need \ncounselling on healthy diet and \nregular physical activity, adapted \nto their capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calor", "score": 0.5093846046121353}, {"source": "content.pdf", "page": 40, "text": "pt studies confirms \nthat type 2 diabetes can be \ndelayed or prevented, but turning \nthis knowledge into large-\nscale impact brings significant \nchallenges. The success of these \nprogrammes depends on the \nfeasibility of identifying, assessing \nand successfully involving high-\nrisk groups (see Box 4). Careful \ndecisions are required about how \nto assess diabetes risk, how to \nsupport those identified as high-\nrisk, and how to ensure care for \nthose diagnosed with diabetes \nas a result of the risk assessment. \nThe individual or high-risk \nInterventions  \nthat promote healthy \ndiet, physical activity \nand weight loss \ncan prevent type 2 \ndiabetes in people  \nat high risk", "score": 0.5061870613666893}, {"source": "content.pdf", "page": 63, "text": "el of alternative \napproaches. PLoS.Med. 2015;12:(5) e1001827.\n9. Screening for Type 2 diabetes. Report of a WHO and International Diabetes Federation meeting WHO/\nNMH/MNC/03.1. Geneva: World Health Organization; 2003.\n10. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P , et al. The effectiveness of mobile-health \ntechnology-based health behaviour change or disease management interventions for health care \nconsumers: a systematic review. PLoS Med. 2013;10:e1001362.\n11. Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes \non glycaemic control: a meta-analysis. Diabetes Medicine. 2011;28:455-463.\n12. Vervloet, M., Dijk, L. van, Bakker, D.H. de, Souverein, P.C., Santen-Reestman, J., Vlijmen, B. van, Aarle, \nM.C.W. van, Hoek, L.S. van der, Bouvy, M.L. Short- and long-term effects of real-time medication \nmonitoring with short message service (SMS) reminders for missed doses on the refill adherence of \npeople with Type 2 diabetes:", "score": 0.5058123468311838}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence on p51 explicitly states “Education of patients in groups is a cost-effective strategy,” directly addressing the question. The answer correctly notes cost-effectiveness is stated and that effectiveness is not explicitly claimed in the provided excerpt. Category selection matches expected (Lifestyle management recommendations)."}, "judge_error": null}
{"id": "Q008", "timestamp_utc": "2025-12-16T06:49:12.801729+00:00", "top_k": 5, "question": "What practical self-care topics should patients understand (e.g., foot hygiene, footwear, daily checks)?", "expected_categories": ["Lifestyle management recommendations"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Patients should understand these practical self-care topics:\n\n- **Healthy lifestyle basics:** importance of a **healthy diet**, **adequate physical activity** (adapted to capability), **avoidance of tobacco**, and **avoidance of harmful alcohol use**. (p50–p51)  \n- **Medication adherence:** follow prescribed treatment for blood glucose control (insulin/oral agents as needed) and medicines to reduce cardiovascular risk. (p50–p51)  \n- **Foot care and prevention:** **foot hygiene** and **appropriate footwear**, plus **regular examination/daily checking of feet** for signs of **neuropathy, impaired blood flow, and skin changes** to help prevent ulcers, gangrene, and amputation. (p51, p53, p50)  \n- **Routine monitoring for complications:** need for **periodic assessment of metabolic control** and screening for complications, including **comprehensive eye examinations** and **urine protein measurement** for early kidney damage. (p51, p53, p50)", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 51, "text": "51MANAGING  DIABETES\n y Integrated management of \ndiabetes and other diseases \n(see Diabetes and other NCDs,  \npage  55).\nThe effectiveness of diabetes \nmanagement ultimately depends \non people’s compliance with \nrecommendations and treatment. \nPatient education is therefore \nan important component of \ndiabetes management. Patients \nneed to understand the principles \nand importance of a healthy \ndiet, adequate physical activity, \navoidance of tobacco and harmful \nuse of alcohol, adherence to \nmedication, foot hygiene and \nappropriate footwear, and the \nneed for periodic assessment \nof metabolic control and the \npresence or progression of \ncomplications (13).\nINTE rvENTIONS TO P rOMOTE \nHEA lTHIE r EATING AND PH ySICA l \nACTI vIT y\nAll people with diabetes need \ncounselling on healthy diet and \nregular physical activity, adapted \nto their capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calor", "score": 0.48778827723462137}, {"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.48600502090742614}, {"source": "content.pdf", "page": 53, "text": "changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational \ntherapy can help minimize the \nimpact of complications on \npeople’s functioning (see Box 9).\nHuMAN r ESO urCES\nA range of health professionals \nis required for the care and \ntreatment of diabetes, including \nphysicians, nurses, dieticians and \nspecialists such as obstetricians, \nophthalmologists, vascular \nsurgeons and physiotherapists.", "score": 0.47296141466381514}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.4557503359599955}, {"source": "content.pdf", "page": 55, "text": "er of patients attending health-care \nfacilities; and increased the annual rate of vascular risk assessments and detection of early stage of \nchronic diabetic complications. A specific training course for foot and wound care has resulted in a \ndeclining rate of foot ulcers and amputations. Capacity-building of care teams in providing standard \ncare for diabetes in children and adolescents is now underway.\ninteractions of which have an \nimpact on its management. In \naddition to cardiovascular diseases, \nageing-related conditions such as \ncognitive decline and physical \ndisability have emerged as frequent \ncomorbid conditions with diabetes. \nDepression is two to three times \nmore common in people with \ndiabetes than in those without, for \nexample (24).\nThe epidemiological transition \noccurring in many low- and middle-\nincome countries is characterized \nby the coexistence of established \ninfectious disease alongside \nemerging NCD epidemics (25). \nSome of these diseases interact, \nmediated", "score": 0.43128041074985757}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 5, "notes": "Retrieval directly supports listed self-care topics: healthy diet/physical activity/tobacco/alcohol avoidance, medication adherence, foot hygiene/appropriate footwear, and need for periodic assessment of metabolic control and complications (p51), plus eye exams and urine protein (p50, p53). However, the answer adds unsupported specifics: \"daily checking\" and monitoring for \"neuropathy, impaired blood flow, and skin changes\" are not explicitly in evidence; p53 mentions preventing foot ulcers but not daily checks or those signs. Otherwise aligned and well-supported."}, "judge_error": null}
{"id": "Q009", "timestamp_utc": "2025-12-16T06:49:22.135930+00:00", "top_k": 5, "question": "What essential medicines are mentioned for glycaemic control in most patients with diabetes (examples)?", "expected_categories": ["Medication protocol guidance"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "In most patients with diabetes, glycaemic control can be managed with WHO Model List essential medicines such as **metformin**, **gliclazide**, and **short-acting and intermediate-acting human or animal insulin** (p52).", "categories": ["Medication protocol guidance"], "evidence": [{"source": "content.pdf", "page": 52, "text": "52 MANAGING  DIABETES\nBlOOD G luCOSE CONT rOl\nThe role of blood glucose control \nin preventing the development \nand progression of complications \nhas been proven in both type 1 \nand type 2 diabetes, with an \nespecially strong relationship \nbetween intensive blood glucose \ncontrol and neuropathy and diabetic \nretinopathy (20, 21). In most patients \nwith diabetes, blood glucose levels \ncan be adequately managed with \nmedicines included in the WHO \nModel list of essential medicines  \n(22). These are metformin, gliclazide, \nand short-acting and intermediate-\nacting human or animal insulin.\nBlood glucose control should \nbe monitored through regular \nmeasurement. People with \ntype 1 diabetes and gestational \ndiabetes need strict control of \nblood glucose which is difficult to \naccomplish and monitor in primary \nhealth care, so they will need more \nfrequent referral to higher levels of \nhealth care.\nGlycated haemoglobin (HbA1c) \nis the method of choice for \nBOx 8. r EvErSING T yPE 2 DIABETES,", "score": 0.6433921717034141}, {"source": "content.pdf", "page": 58, "text": "s.\nAn increasing number of \ncostly blood-glucose lowering \nmedications are becoming \navailable, but WHO’s Model list \nof essential medicines  contains \neffective, established and cost-\neffective treatments that should \nform the basis of therapeutic \noptions. This applies not just for \nlow- and middle-income resource \nsettings but high-income settings \ntoo, as there is the chance that \nexpenditure on non-essential \nmedicines in these countries may \ncontribute to catastrophic health \nexpenditure (35, 36) . Availability \nin public health-care settings can \ndepend on the inclusion of the \nmedicine on countries’ National \nEssential Medicines Lists (NEML), \nand whether the NEML serves as \nbasis for procurement, training of \nstaff, reimbursement systems and \nprescription decisions.\nGovernments should secure \nfunding for essential medicines \nand technologies to diagnose and \nmanage diabetes. Affordability \ndepends mainly on the use of \ngeneric medicines and their \nuse should be promoted – and", "score": 0.6310536405403921}, {"source": "content.pdf", "page": 64, "text": "64 MANAGING  DIABETES\n20. The effect of intensive treatment of diabetes on the development and progression of long-term \ncomplications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial \nResearch Group. New England Journal of Medicine. 1993;329:(14)977–986.\n21. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment \nand risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study \n(UKPDS) Group. Lancet. 1998;352:(9131)837–853.\n22. WHO Model list of Essential Medicines. Geneva: World Health Organization; 2015.\n23. Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, et al. Intensive attention \nimproves glycaemic control in insulin-dependent diabetes without further advantage from home blood \nglucose monitoring: results of a controlled trial. British Medical Journal (Clinical Research Edition). \n1982;285:(6350)1233–1240.\n24. Roy T, Lloyd CE. Epidemiology of depr", "score": 0.5863034008378362}, {"source": "content.pdf", "page": 58, "text": "58 MANAGING  DIABETES\nOrienting these services around \npeople’s needs, not just diseases, \nand approaching  them as \nparticipants of care, not just \nbeneficiaries, will help ensure that \npeople receive the right care at the \nright time. WHO’s Global strategy \non people-centred and integrated \nhealth services  outlines different \npathways to empower and engage \npeople; to strengthen health \ngovernance and accountability; \nto reorient the model of health-\ncare services; to coordinate \nservices; and to create an enabling \nenvironment (34).\n3.4 ACCESS TO ESSENTIA l \nMEDICINES AND BASIC \nTECHNOl OGIES\nAll people with type 1 diabetes, \nand many with type 2, require \nmedication to reduce their blood \nglucose levels. A discussion of \ndiabetes management must \ntherefore include a closer look at \naccess to essential medicines and \nbasic technologies.\nAn increasing number of \ncostly blood-glucose lowering \nmedications are becoming \navailable, but WHO’s Model list \nof essential medicines  contains", "score": 0.5737262929645418}, {"source": "content.pdf", "page": 72, "text": "72 NATIONAl CAPACIT y f Or P rE vENTION  AND  CONT rOl O f DIABETES : A  SNAPSHOT\ncountries (54  countries). Further, \nthe reported general availability of \ninsulin in the WHO Region of the \nAmericas and the European Region \nis more than double that of the \nWHO African Region and South-\nEast Asia Region.\nRegarding oral medications for \nglucose control, in 82% of countries \n(145  countries) metformin is \nreported as generally available, \ncompared to 69% (123 countries) \nreporting general availability of \nsulphonylurea(s). Very few low-\nincome countries report availability \nof both. Among high-income \ncountries, more than 90% report \nthat metformin and sulphonylurea(s) \nare generally available.\nBASIC TECHNO lOGIES IN P rIMA ry \nCArE fACI lITIES\nEssential technologies necessary \nfor early detection, diagnosis and \nmonitoring of diabetes in primary \nhealth care include weighing \nmachines, measurement tapes, \nglucometers, blood glucose test \nstrips, urine protein test strips and \nurine keto", "score": 0.5727573150611028}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence on p52 explicitly lists essential medicines for blood glucose control in most patients: metformin, gliclazide, and short-/intermediate-acting human or animal insulin. The answer accurately reflects this and cites p52. Category matches medication protocol guidance."}, "judge_error": null}
{"id": "Q010", "timestamp_utc": "2025-12-16T06:49:32.500082+00:00", "top_k": 5, "question": "What monitoring approach is recommended for glycaemic control (HbA1c vs glucose), and what frequency guidance is mentioned?", "expected_categories": ["Medication protocol guidance", "Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "- **Preferred monitoring approach:** **Glycated haemoglobin (HbA1c) is the method of choice** for monitoring glycaemic control. Advantages noted include that the patient **does not need to be fasting**, and HbA1c reflects **average blood glucose over the past few weeks**. (p52, p53, p48)  \n- **If HbA1c not available:** Because HbA1c testing is **more costly** and may be less available, **fasting or post-meal blood glucose** is an acceptable substitute. (p53)  \n- **Frequency guidance:** HbA1c should **ideally be measured twice a year in people with type 2 diabetes**, and **more frequently in those with type 1 diabetes**. (p53)  \n- **Self-monitoring:** **Self-monitoring of blood glucose is recommended for patients receiving insulin**, with a plan with their health provider on how to adjust insulin, food intake, and physical activity based on results. (p53)", "categories": ["Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 53, "text": "53MANAGING  DIABETES\nmonitoring glycaemic control in \ndiabetes. An advantage of using \nHbA1c is that the patient does not \nneed to be in a fasting state. Ideally \nit should be measured twice a year \nin people with type 2 diabetes \nand more frequently in those with \ntype 1 diabetes. However, HbA1c \ntesting is more costly than glucose \nmeasurement, and therefore less \nreadily available. If HbA1c testing is \nnot available, fasting or post-meal \nblood glucose is an acceptable \nsubstitute.\nSelf-monitoring of blood glucose \nis recommended for patients \nreceiving insulin, and to have a \nplan of action with their health \nprovider on how to adjust insulin \ndosage, food intake and physical \nactivity according to their blood \nglucose levels. Availability of \nself-monitoring devices and strips \nhas not been assessed globally. \nAnecdotal evidence suggests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSom", "score": 0.6765053317425411}, {"source": "content.pdf", "page": 52, "text": "52 MANAGING  DIABETES\nBlOOD G luCOSE CONT rOl\nThe role of blood glucose control \nin preventing the development \nand progression of complications \nhas been proven in both type 1 \nand type 2 diabetes, with an \nespecially strong relationship \nbetween intensive blood glucose \ncontrol and neuropathy and diabetic \nretinopathy (20, 21). In most patients \nwith diabetes, blood glucose levels \ncan be adequately managed with \nmedicines included in the WHO \nModel list of essential medicines  \n(22). These are metformin, gliclazide, \nand short-acting and intermediate-\nacting human or animal insulin.\nBlood glucose control should \nbe monitored through regular \nmeasurement. People with \ntype 1 diabetes and gestational \ndiabetes need strict control of \nblood glucose which is difficult to \naccomplish and monitor in primary \nhealth care, so they will need more \nfrequent referral to higher levels of \nhealth care.\nGlycated haemoglobin (HbA1c) \nis the method of choice for \nBOx 8. r EvErSING T yPE 2 DIABETES,", "score": 0.5690170225557359}, {"source": "content.pdf", "page": 83, "text": "83ANNE xES\nANNE x A. CurrENT w HO rECOMMENDATIONS f Or THE DIAGNOSTIC C rITE rIA f Or DIABETES AND \nINTEr MEDIATE H yPEr GlyCAEMIA\nIn people who do not have symptoms, a positive test for diabetes should be repeated on another day.  1 \nBlood glucose measurement is relatively simple and cheap and should be available at primary health-care level.\n1. Source: Definition and diagnosis of diabetes and intermediate hyperglycaemia. Geneva: World Health Organization; 2006.\nDiabetes\nFasting plasma glucose\n2-h plasma glucose*\nHbA1c\n≥ 7.0 mmol/L (126 mg/dl)\nor\n≥ 11.1 mmol/L (200 mg/dl)\nor\n≥ 6.5%\nImpaired glucose tolerance (IGT)\nFasting plasma glucose\n2-h plasma glucose*\n< 7.0 mmol/L (126 mg/dl)\nand\n≥ 7.8 and < 11.1 mmol/L\n(140 mg/dl and 200 mg/dl)\nImpaired fasting glucose (IFG)\nFasting plasma glucose\n2-h plasma glucose*\n6.1 to 6.9 mmol/L (110 mg/dl to 125 mg/dl)\nand (if measured)\n< 7.8 mmol/L (140 mg/dl)\nGestational diabetes (GDM)\nOne or more of the following:\nFasting plasma glucose\n1-h plasma gluc", "score": 0.5684641823410325}, {"source": "content.pdf", "page": 48, "text": "n (HbA1c), even if the \npatient is not in a fasting state \n(5). HbA1c reflects the average \nblood glucose concentration over \nthe past few weeks, rather than \nthe blood glucose concentration \nat that moment (reflected by \nthe fasting and 2-hour blood \nglucose measurements mentioned \nabove). However, the test is \nmore costly than blood glucose \nmeasurement (5).\nBlood glucose measurement to \ndiagnose diabetes should be \navailable at the primary health-\ncare level. If laboratory analysis \nof venous plasma glucose is not \nfeasible, point-of-care devices that \nmeasure glucose in capillary blood \nand meet current International \nStandardization Organization \n(ISO) standards are an acceptable \nalternative. Unfortunately, testing \ndevices and supplies are often not \navailable where or when necessary – \none survey found the availability of \nblood glucose meters ranged from \n21% to 100% in facilities visited in \nfive developing countries (6).\nEArly DETECTION O f T yPE 2 DIABETES\nWhether people sh", "score": 0.5661809852000848}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.5213636670537237}]}, "metrics": {"category_jaccard": 0.5, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 3, "notes": "Answer accurately reflects evidence on HbA1c preferred, non-fasting advantage, reflects past weeks, cost/availability, glucose substitutes, twice-yearly T2DM and more frequent T1DM, and SMBG for insulin users (pp48,53). Category mapping is partial: content is about monitoring frequency/approach (fits complication screening schedules broadly) but also overlaps with medication protocol guidance; model only selected one category while expected includes both."}, "judge_error": null}
{"id": "Q011", "timestamp_utc": "2025-12-16T06:49:44.581225+00:00", "top_k": 5, "question": "When HbA1c testing is not available, what alternative is suggested for monitoring glycaemic control?", "expected_categories": ["Medication protocol guidance"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "When HbA1c testing is not available, **fasting or post-meal blood glucose measurement** is suggested as an acceptable substitute for monitoring glycaemic control. (p53)", "categories": ["Lifestyle management recommendations", "Medication protocol guidance", "Complication screening schedules", "Referral criteria"], "evidence": [{"source": "content.pdf", "page": 53, "text": "53MANAGING  DIABETES\nmonitoring glycaemic control in \ndiabetes. An advantage of using \nHbA1c is that the patient does not \nneed to be in a fasting state. Ideally \nit should be measured twice a year \nin people with type 2 diabetes \nand more frequently in those with \ntype 1 diabetes. However, HbA1c \ntesting is more costly than glucose \nmeasurement, and therefore less \nreadily available. If HbA1c testing is \nnot available, fasting or post-meal \nblood glucose is an acceptable \nsubstitute.\nSelf-monitoring of blood glucose \nis recommended for patients \nreceiving insulin, and to have a \nplan of action with their health \nprovider on how to adjust insulin \ndosage, food intake and physical \nactivity according to their blood \nglucose levels. Availability of \nself-monitoring devices and strips \nhas not been assessed globally. \nAnecdotal evidence suggests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSom", "score": 0.6449471616268129}, {"source": "content.pdf", "page": 48, "text": "n (HbA1c), even if the \npatient is not in a fasting state \n(5). HbA1c reflects the average \nblood glucose concentration over \nthe past few weeks, rather than \nthe blood glucose concentration \nat that moment (reflected by \nthe fasting and 2-hour blood \nglucose measurements mentioned \nabove). However, the test is \nmore costly than blood glucose \nmeasurement (5).\nBlood glucose measurement to \ndiagnose diabetes should be \navailable at the primary health-\ncare level. If laboratory analysis \nof venous plasma glucose is not \nfeasible, point-of-care devices that \nmeasure glucose in capillary blood \nand meet current International \nStandardization Organization \n(ISO) standards are an acceptable \nalternative. Unfortunately, testing \ndevices and supplies are often not \navailable where or when necessary – \none survey found the availability of \nblood glucose meters ranged from \n21% to 100% in facilities visited in \nfive developing countries (6).\nEArly DETECTION O f T yPE 2 DIABETES\nWhether people sh", "score": 0.615625557943799}, {"source": "content.pdf", "page": 83, "text": "83ANNE xES\nANNE x A. CurrENT w HO rECOMMENDATIONS f Or THE DIAGNOSTIC C rITE rIA f Or DIABETES AND \nINTEr MEDIATE H yPEr GlyCAEMIA\nIn people who do not have symptoms, a positive test for diabetes should be repeated on another day.  1 \nBlood glucose measurement is relatively simple and cheap and should be available at primary health-care level.\n1. Source: Definition and diagnosis of diabetes and intermediate hyperglycaemia. Geneva: World Health Organization; 2006.\nDiabetes\nFasting plasma glucose\n2-h plasma glucose*\nHbA1c\n≥ 7.0 mmol/L (126 mg/dl)\nor\n≥ 11.1 mmol/L (200 mg/dl)\nor\n≥ 6.5%\nImpaired glucose tolerance (IGT)\nFasting plasma glucose\n2-h plasma glucose*\n< 7.0 mmol/L (126 mg/dl)\nand\n≥ 7.8 and < 11.1 mmol/L\n(140 mg/dl and 200 mg/dl)\nImpaired fasting glucose (IFG)\nFasting plasma glucose\n2-h plasma glucose*\n6.1 to 6.9 mmol/L (110 mg/dl to 125 mg/dl)\nand (if measured)\n< 7.8 mmol/L (140 mg/dl)\nGestational diabetes (GDM)\nOne or more of the following:\nFasting plasma glucose\n1-h plasma gluc", "score": 0.5663694621121897}, {"source": "content.pdf", "page": 52, "text": "52 MANAGING  DIABETES\nBlOOD G luCOSE CONT rOl\nThe role of blood glucose control \nin preventing the development \nand progression of complications \nhas been proven in both type 1 \nand type 2 diabetes, with an \nespecially strong relationship \nbetween intensive blood glucose \ncontrol and neuropathy and diabetic \nretinopathy (20, 21). In most patients \nwith diabetes, blood glucose levels \ncan be adequately managed with \nmedicines included in the WHO \nModel list of essential medicines  \n(22). These are metformin, gliclazide, \nand short-acting and intermediate-\nacting human or animal insulin.\nBlood glucose control should \nbe monitored through regular \nmeasurement. People with \ntype 1 diabetes and gestational \ndiabetes need strict control of \nblood glucose which is difficult to \naccomplish and monitor in primary \nhealth care, so they will need more \nfrequent referral to higher levels of \nhealth care.\nGlycated haemoglobin (HbA1c) \nis the method of choice for \nBOx 8. r EvErSING T yPE 2 DIABETES,", "score": 0.5308160448213773}, {"source": "content.pdf", "page": 75, "text": "ts, considered the \noptimal tool for monitoring blood \nglucose levels (see Part 3), are \nmostly unavailable in low- and \nmiddle-income countries, but in \nmany settings even more basic \ntechnologies for diagnosis and \nmonitoring are also lacking. Among \nlow- and lower middle-income \ncountries, only one in three (35% \nand 36% of countries respectively) \ncan report that the most basic \ntechnologies to measure height \nand weight, blood glucose, and \nurine strips for glucose and \nketone measurement are generally \navailable in primary care facilities. \nInsulin, along with metformin \nand sulphonylurea(s), is generally \navailable in only a minority of \nlow-income countries. This lack \nof access to basic technologies \nand essential medicines stands \nin sharp contrast to the reported \nwidespread availability of these \nitems in high-income countries.\nrEfErENCES\n1. How WHO will report in 2017 to the United Nations General Assembly on the progress achieved in the \nimplementation of commitments incl", "score": 0.4916847570308508}]}, "metrics": {"category_jaccard": 0.25, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 2, "notes": "Evidence on p53 directly supports the answer: if HbA1c unavailable, fasting or post-meal blood glucose is an acceptable substitute. Answer is fully grounded with no extra claims. Expected category was only Medication protocol guidance, but model also assigned extra unrelated categories (lifestyle, complication screening, referral), reducing category correctness."}, "judge_error": null}
{"id": "Q012", "timestamp_utc": "2025-12-16T06:49:53.364162+00:00", "top_k": 5, "question": "Who is self-monitoring of blood glucose recommended for, and why?", "expected_categories": ["Medication protocol guidance"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Self-monitoring of blood glucose is **recommended for patients receiving insulin** (p53). It is recommended so that patients can **work with their health provider on a plan of action** to **adjust insulin dose, food intake, and physical activity according to their blood glucose levels** (p53).", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 53, "text": "53MANAGING  DIABETES\nmonitoring glycaemic control in \ndiabetes. An advantage of using \nHbA1c is that the patient does not \nneed to be in a fasting state. Ideally \nit should be measured twice a year \nin people with type 2 diabetes \nand more frequently in those with \ntype 1 diabetes. However, HbA1c \ntesting is more costly than glucose \nmeasurement, and therefore less \nreadily available. If HbA1c testing is \nnot available, fasting or post-meal \nblood glucose is an acceptable \nsubstitute.\nSelf-monitoring of blood glucose \nis recommended for patients \nreceiving insulin, and to have a \nplan of action with their health \nprovider on how to adjust insulin \ndosage, food intake and physical \nactivity according to their blood \nglucose levels. Availability of \nself-monitoring devices and strips \nhas not been assessed globally. \nAnecdotal evidence suggests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSom", "score": 0.5633287888030197}, {"source": "content.pdf", "page": 52, "text": "52 MANAGING  DIABETES\nBlOOD G luCOSE CONT rOl\nThe role of blood glucose control \nin preventing the development \nand progression of complications \nhas been proven in both type 1 \nand type 2 diabetes, with an \nespecially strong relationship \nbetween intensive blood glucose \ncontrol and neuropathy and diabetic \nretinopathy (20, 21). In most patients \nwith diabetes, blood glucose levels \ncan be adequately managed with \nmedicines included in the WHO \nModel list of essential medicines  \n(22). These are metformin, gliclazide, \nand short-acting and intermediate-\nacting human or animal insulin.\nBlood glucose control should \nbe monitored through regular \nmeasurement. People with \ntype 1 diabetes and gestational \ndiabetes need strict control of \nblood glucose which is difficult to \naccomplish and monitor in primary \nhealth care, so they will need more \nfrequent referral to higher levels of \nhealth care.\nGlycated haemoglobin (HbA1c) \nis the method of choice for \nBOx 8. r EvErSING T yPE 2 DIABETES,", "score": 0.49416012461126596}, {"source": "content.pdf", "page": 83, "text": "83ANNE xES\nANNE x A. CurrENT w HO rECOMMENDATIONS f Or THE DIAGNOSTIC C rITE rIA f Or DIABETES AND \nINTEr MEDIATE H yPEr GlyCAEMIA\nIn people who do not have symptoms, a positive test for diabetes should be repeated on another day.  1 \nBlood glucose measurement is relatively simple and cheap and should be available at primary health-care level.\n1. Source: Definition and diagnosis of diabetes and intermediate hyperglycaemia. Geneva: World Health Organization; 2006.\nDiabetes\nFasting plasma glucose\n2-h plasma glucose*\nHbA1c\n≥ 7.0 mmol/L (126 mg/dl)\nor\n≥ 11.1 mmol/L (200 mg/dl)\nor\n≥ 6.5%\nImpaired glucose tolerance (IGT)\nFasting plasma glucose\n2-h plasma glucose*\n< 7.0 mmol/L (126 mg/dl)\nand\n≥ 7.8 and < 11.1 mmol/L\n(140 mg/dl and 200 mg/dl)\nImpaired fasting glucose (IFG)\nFasting plasma glucose\n2-h plasma glucose*\n6.1 to 6.9 mmol/L (110 mg/dl to 125 mg/dl)\nand (if measured)\n< 7.8 mmol/L (140 mg/dl)\nGestational diabetes (GDM)\nOne or more of the following:\nFasting plasma glucose\n1-h plasma gluc", "score": 0.48141899294611246}, {"source": "content.pdf", "page": 53, "text": "ests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSome data indicate that less \ncostly self-monitoring by urine \nglucose measurement could be \nan acceptable alternative when \nblood glucose self-monitoring is \nnot possible (23).\nMEDICATION f Or ASSOCIATED \nCArDIO vASCul Ar DISEASE r ISk \nfACTO rS\nComprehensive reduction of \ncardiovascular disease risk factors, \nincluding the control of blood \npressure and lipids in addition to \nblood glucose, is of vital importance \nin preventing the development of \ncardiovascular disease in diabetes, \nbut also in preventing microvascular \ncomplications. This can be achieved \nwith generic medicines from WHO \nModel list of essential medicines  \n(22) (thiazide diuretic, ACE-inhibitor, \nbeta blockers, statin).\nSCr EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress o", "score": 0.4751896107567659}, {"source": "content.pdf", "page": 48, "text": "n (HbA1c), even if the \npatient is not in a fasting state \n(5). HbA1c reflects the average \nblood glucose concentration over \nthe past few weeks, rather than \nthe blood glucose concentration \nat that moment (reflected by \nthe fasting and 2-hour blood \nglucose measurements mentioned \nabove). However, the test is \nmore costly than blood glucose \nmeasurement (5).\nBlood glucose measurement to \ndiagnose diabetes should be \navailable at the primary health-\ncare level. If laboratory analysis \nof venous plasma glucose is not \nfeasible, point-of-care devices that \nmeasure glucose in capillary blood \nand meet current International \nStandardization Organization \n(ISO) standards are an acceptable \nalternative. Unfortunately, testing \ndevices and supplies are often not \navailable where or when necessary – \none survey found the availability of \nblood glucose meters ranged from \n21% to 100% in facilities visited in \nfive developing countries (6).\nEArly DETECTION O f T yPE 2 DIABETES\nWhether people sh", "score": 0.45636208387839283}]}, "metrics": {"category_jaccard": 0.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 2, "notes": "Evidence on p53 explicitly states SMBG is recommended for patients receiving insulin and to have a plan with their provider to adjust insulin dosage, food intake, and physical activity. Answer matches this and adds no unsupported claims. However, the selected category should be Medication protocol guidance (insulin/SMBG action plan); model labeled it Lifestyle management recommendations, so category alignment is poor."}, "judge_error": null}
{"id": "Q013", "timestamp_utc": "2025-12-16T06:50:03.251194+00:00", "top_k": 5, "question": "What barriers to self-monitoring (devices/strips) are noted, and what lower-cost alternative is mentioned?", "expected_categories": ["Medication protocol guidance"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "- **Barriers noted for self-monitoring (devices/strips):** Self-monitoring devices and strips are often **not available** for many people on insulin treatment, with **cost cited as the most frequent reason** (p53). Availability of self-monitoring devices and strips “has not been assessed globally,” but anecdotal evidence indicates limited access (p53).  \n- **Lower-cost alternative mentioned:** **Urine glucose measurement** is noted as a **less costly** self-monitoring alternative when blood glucose self-monitoring is not possible (p53).", "categories": ["Lifestyle management recommendations"], "evidence": [{"source": "content.pdf", "page": 53, "text": "53MANAGING  DIABETES\nmonitoring glycaemic control in \ndiabetes. An advantage of using \nHbA1c is that the patient does not \nneed to be in a fasting state. Ideally \nit should be measured twice a year \nin people with type 2 diabetes \nand more frequently in those with \ntype 1 diabetes. However, HbA1c \ntesting is more costly than glucose \nmeasurement, and therefore less \nreadily available. If HbA1c testing is \nnot available, fasting or post-meal \nblood glucose is an acceptable \nsubstitute.\nSelf-monitoring of blood glucose \nis recommended for patients \nreceiving insulin, and to have a \nplan of action with their health \nprovider on how to adjust insulin \ndosage, food intake and physical \nactivity according to their blood \nglucose levels. Availability of \nself-monitoring devices and strips \nhas not been assessed globally. \nAnecdotal evidence suggests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSom", "score": 0.5501349015750037}, {"source": "content.pdf", "page": 75, "text": "ts, considered the \noptimal tool for monitoring blood \nglucose levels (see Part 3), are \nmostly unavailable in low- and \nmiddle-income countries, but in \nmany settings even more basic \ntechnologies for diagnosis and \nmonitoring are also lacking. Among \nlow- and lower middle-income \ncountries, only one in three (35% \nand 36% of countries respectively) \ncan report that the most basic \ntechnologies to measure height \nand weight, blood glucose, and \nurine strips for glucose and \nketone measurement are generally \navailable in primary care facilities. \nInsulin, along with metformin \nand sulphonylurea(s), is generally \navailable in only a minority of \nlow-income countries. This lack \nof access to basic technologies \nand essential medicines stands \nin sharp contrast to the reported \nwidespread availability of these \nitems in high-income countries.\nrEfErENCES\n1. How WHO will report in 2017 to the United Nations General Assembly on the progress achieved in the \nimplementation of commitments incl", "score": 0.548375024244834}, {"source": "content.pdf", "page": 53, "text": "ests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSome data indicate that less \ncostly self-monitoring by urine \nglucose measurement could be \nan acceptable alternative when \nblood glucose self-monitoring is \nnot possible (23).\nMEDICATION f Or ASSOCIATED \nCArDIO vASCul Ar DISEASE r ISk \nfACTO rS\nComprehensive reduction of \ncardiovascular disease risk factors, \nincluding the control of blood \npressure and lipids in addition to \nblood glucose, is of vital importance \nin preventing the development of \ncardiovascular disease in diabetes, \nbut also in preventing microvascular \ncomplications. This can be achieved \nwith generic medicines from WHO \nModel list of essential medicines  \n(22) (thiazide diuretic, ACE-inhibitor, \nbeta blockers, statin).\nSCr EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress o", "score": 0.5292967340221819}, {"source": "content.pdf", "page": 73, "text": "73NATIONAl CAPACIT y f Or P rE vENTION  AND  CONT rOl O f DIABETES : A  SNAPSHOT\nmeasurement, and urine strips for \nglucose and ketone measurement. \nThere is a strong income gradient \nin reported availability of these \nessential technologies. Only one \nin three low-income and lower \nmiddle-income countries report \nhaving all three of these basic, \nessential technologies generally \navailable, in contrast with nearly \ntwo in three of upper-middle and \nnearly all of high-income countries \n(not shown).\nFigure 12 shows the reported \navailability of other, more \nexpensive or sophisticated \ntechnologies and procedures \nuseful for early detection, \ndiagnosis and management of \ndiabetes and its complications: \noral glucose tolerance test, \nglycated haemoglobin (HbA1c) \ntest, foot vibration by tuning fork, \nDoppler ultrasound testing of foot \nvascular status, and examination \nof the eye with dilated pupil \n(dilated fundus examination). \nIt is clear that these additional \ntechnologies are much mo", "score": 0.51822901356873}, {"source": "content.pdf", "page": 58, "text": "technologies to diagnose and \nmanage diabetes. Affordability \ndepends mainly on the use of \ngeneric medicines and their \nuse should be promoted – and \ntheir quality assured – through \na strong national regulatory \nsystem. Responsible use of \nmedicines can be promoted by \nthe implementation of evidence-\nbased guidelines and treatment \nprotocols. Along with better \nprocurement and policies for \ngeneric substitution, affordability \nfor patients or for the system \n(if medicines are given free to \npatients or if a national health \ninsurance system is in place) could \nbe improved by regulation of mark-\nups in the supply chain, and tax or \ntariff exemption (see Box 11).\nINS ulIN AND O rAl H yPOG lyCAEMIC \nAGENTS\nPeople with type 1 diabetes \nrequire insulin for survival – \nwithout insulin, even for a short \ntime, these individuals may face \nlife-threatening consequences. \nYet an array of international \nand national barriers interact to \nhamper access to insulin, and \nmany in low- and middle-in", "score": 0.517403101931022}]}, "metrics": {"category_jaccard": 0.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 1, "notes": "Retrieval includes direct evidence on self-monitoring unavailability due to cost and urine glucose as a less costly alternative (p53). Answer adds an unsupported claim that availability “has not been assessed globally”/“anecdotal evidence indicates limited access,” which is not in provided p53 excerpts (though other pages discuss availability broadly). Category mismatch: question/answer are about monitoring access/cost, but model labeled as Lifestyle management; expected category Medication protocol guidance."}, "judge_error": null}
{"id": "Q014", "timestamp_utc": "2025-12-16T06:50:12.608608+00:00", "top_k": 5, "question": "What medicines are mentioned for cardiovascular risk-factor management in people with diabetes (examples)?", "expected_categories": ["Medication protocol guidance"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Medicines mentioned for **cardiovascular risk-factor management** in people with diabetes include **thiazide diuretics, ACE inhibitors, beta blockers, and statins** (examples from the WHO Model List of Essential Medicines) (p53).", "categories": ["Medication protocol guidance"], "evidence": [{"source": "content.pdf", "page": 53, "text": "ests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSome data indicate that less \ncostly self-monitoring by urine \nglucose measurement could be \nan acceptable alternative when \nblood glucose self-monitoring is \nnot possible (23).\nMEDICATION f Or ASSOCIATED \nCArDIO vASCul Ar DISEASE r ISk \nfACTO rS\nComprehensive reduction of \ncardiovascular disease risk factors, \nincluding the control of blood \npressure and lipids in addition to \nblood glucose, is of vital importance \nin preventing the development of \ncardiovascular disease in diabetes, \nbut also in preventing microvascular \ncomplications. This can be achieved \nwith generic medicines from WHO \nModel list of essential medicines  \n(22) (thiazide diuretic, ACE-inhibitor, \nbeta blockers, statin).\nSCr EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress o", "score": 0.5602901610820719}, {"source": "content.pdf", "page": 56, "text": "56 MANAGING  DIABETES\nexample, includes blood glucose \ncontrol and counselling (for \nhealthy diet and physical activity), \nand, similarly, management of \ndiabetes includes anti-hypertensive \nmedications at lower levels of blood \npressure than for non-diabetics \n(13). An organized and integrated \nhealth system is necessary to \ndeliver optimal diabetes care. \nRelatively simple measures can be \nimplemented, including standard \nprotocols and clear referral \npathways between different \nhealth-care providers and different \nlevels of care.\nA core set of such interventions is \ndefined in the WHO PEN package, \nwhich includes interventions for \ndetection, prevention, treatment \nand care of diabetes, cardiovascular \ndisease, chronic respiratory disease \nand cancer through a primary \nhealth-care approach (13). They are \nevidence-based, cost-effective and \nfeasible for implementation – even \nin low-resource settings. WHO \nPEN equips both physicians and \nnon-physician health workers in \nprimary care", "score": 0.5281850691168799}, {"source": "content.pdf", "page": 52, "text": "52 MANAGING  DIABETES\nBlOOD G luCOSE CONT rOl\nThe role of blood glucose control \nin preventing the development \nand progression of complications \nhas been proven in both type 1 \nand type 2 diabetes, with an \nespecially strong relationship \nbetween intensive blood glucose \ncontrol and neuropathy and diabetic \nretinopathy (20, 21). In most patients \nwith diabetes, blood glucose levels \ncan be adequately managed with \nmedicines included in the WHO \nModel list of essential medicines  \n(22). These are metformin, gliclazide, \nand short-acting and intermediate-\nacting human or animal insulin.\nBlood glucose control should \nbe monitored through regular \nmeasurement. People with \ntype 1 diabetes and gestational \ndiabetes need strict control of \nblood glucose which is difficult to \naccomplish and monitor in primary \nhealth care, so they will need more \nfrequent referral to higher levels of \nhealth care.\nGlycated haemoglobin (HbA1c) \nis the method of choice for \nBOx 8. r EvErSING T yPE 2 DIABETES,", "score": 0.5236749087338517}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.523649911747401}, {"source": "content.pdf", "page": 63, "text": "real-time medication \nmonitoring with short message service (SMS) reminders for missed doses on the refill adherence of \npeople with Type 2 diabetes: evidence from a randomised controlled trial. Diabetic Medicine: 2014, \n31(7), 821-828.\n13. Implementation tools: Package of Essential Noncommunicable (PEN) Disease Interventions for Primary \nHealth Care in Low-Resource Settings. Geneva: World Health Organization; 2013.\n14. Fats and fatty acids in human nutrition: report of an expert consultation. FAO Food and Nutrition Paper \n91. Rome: Food and Agriculture Organization of the United Nations; 2010.\n15. Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary \ncomponents and nutritional strategies. Lancet. 2014;383:(9933)1999–2007.\n16. Guideline: Sugars intake for adults and children. Geneva: World Health Organization; 2015.\n17. Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:(4)1047–1055.\n18. Maggard-Gibbons M, Maglione M, Livhits", "score": 0.5170913779619319}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 0, "groundedness": 2, "category_correctness": 5, "notes": "Evidence snippet for p53 is truncated and does not show the specific medicines (thiazides, ACE inhibitors, beta blockers, statins). Provided evidence only generally mentions medication for cardiovascular risk factors and antihypertensives, without listing these examples. Thus answer is largely unsupported. Category matches expected (medication protocol guidance)."}, "judge_error": null}
{"id": "Q015", "timestamp_utc": "2025-12-16T06:50:19.286839+00:00", "top_k": 5, "question": "Why is blood glucose control important in preventing or slowing diabetic complications such as retinopathy and neuropathy?", "expected_categories": ["Medication protocol guidance"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "This question is outside the supported diabetes guideline topics, or no supporting evidence was retrieved.", "categories": [], "evidence": [{"source": "content.pdf", "page": 52, "text": "52 MANAGING  DIABETES\nBlOOD G luCOSE CONT rOl\nThe role of blood glucose control \nin preventing the development \nand progression of complications \nhas been proven in both type 1 \nand type 2 diabetes, with an \nespecially strong relationship \nbetween intensive blood glucose \ncontrol and neuropathy and diabetic \nretinopathy (20, 21). In most patients \nwith diabetes, blood glucose levels \ncan be adequately managed with \nmedicines included in the WHO \nModel list of essential medicines  \n(22). These are metformin, gliclazide, \nand short-acting and intermediate-\nacting human or animal insulin.\nBlood glucose control should \nbe monitored through regular \nmeasurement. People with \ntype 1 diabetes and gestational \ndiabetes need strict control of \nblood glucose which is difficult to \naccomplish and monitor in primary \nhealth care, so they will need more \nfrequent referral to higher levels of \nhealth care.\nGlycated haemoglobin (HbA1c) \nis the method of choice for \nBOx 8. r EvErSING T yPE 2 DIABETES,", "score": 0.6030466462984176}, {"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.5781624883587058}, {"source": "content.pdf", "page": 13, "text": "mally high blood glucose \ncan have a life-threatening impact \nif it triggers conditions such as \ndiabetic ketoacidosis (DKA) in \ntypes 1 and 2, and hyperosmolar \ncoma in type 2. Abnormally low \nblood glucose can occur in all \ntypes of diabetes and may result in \nseizures or loss of consciousness. It \nmay happen after skipping a meal \nor exercising more than usual, \nor if the dosage of anti-diabetic \nmedication is too high.\nOver time diabetes can damage \nthe heart, blood vessels, eyes, \nkidneys and nerves, and increase \nthe risk of heart disease and \nstroke. Such damage can result \nin reduced blood flow, which – \ncombined with nerve damage \n(neuropathy) in the feet – increases \nthe chance of foot ulcers, infection \nand the eventual need for limb \namputation. Diabetic retinopathy \nis an important cause of blindness \nand occurs as a result of long-\nterm accumulated damage to the \nsmall blood vessels in the retina. \nDiabetes is among the leading \ncauses of kidney failure.\nUncontrolled diab", "score": 0.573718655687099}, {"source": "content.pdf", "page": 51, "text": "have a beneficial effect on insulin \naction, blood glucose control \nand metabolic abnormalities \nassociated with diabetes. Physical \nactivity can also be beneficial in \nreducing cardiovascular disease \nrisk factors. Activity should be \nregular and ideally combine \naerobic exercise with resistance \ntraining (19).\nBlood glucose control \nis important in \npreventing and slowing \nthe progression of \ncomplications", "score": 0.527757010745836}, {"source": "content.pdf", "page": 53, "text": "ests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSome data indicate that less \ncostly self-monitoring by urine \nglucose measurement could be \nan acceptable alternative when \nblood glucose self-monitoring is \nnot possible (23).\nMEDICATION f Or ASSOCIATED \nCArDIO vASCul Ar DISEASE r ISk \nfACTO rS\nComprehensive reduction of \ncardiovascular disease risk factors, \nincluding the control of blood \npressure and lipids in addition to \nblood glucose, is of vital importance \nin preventing the development of \ncardiovascular disease in diabetes, \nbut also in preventing microvascular \ncomplications. This can be achieved \nwith generic medicines from WHO \nModel list of essential medicines  \n(22) (thiazide diuretic, ACE-inhibitor, \nbeta blockers, statin).\nSCr EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress o", "score": 0.516064437579977}]}, "metrics": {"category_jaccard": 0.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 3, "groundedness": 4, "category_correctness": 1, "notes": "Evidence directly supports that blood glucose control prevents development/progression of complications and has strong relationship with neuropathy/retinopathy, so retrieval is relevant. The system answer incorrectly claims no supporting evidence/topics, contradicting provided evidence (ungrounded vs evidence). Expected category is Medication protocol guidance; the question/evidence are general complication prevention, not a protocol, and no category was assigned, so category correctness is low."}, "judge_error": null}
{"id": "Q016", "timestamp_utc": "2025-12-16T06:50:35.709231+00:00", "top_k": 5, "question": "In settings with limited specialist availability, what workforce or task-sharing approaches are mentioned for diabetes care delivery?", "expected_categories": ["Medication protocol guidance", "Referral criteria"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "In settings with limited specialist availability, the evidence mentions these workforce/task-sharing approaches for diabetes care:\n\n- **Up-skilling available health professionals** to deliver diabetes care as an “innovative solution” when trained diabetes professionals are not available. (p54)  \n- **Training lay people** to provide **protocol-driven diabetes care**. (p54)  \n- Using **WHO PEN management protocols** that are designed for **non-medically qualified health-care workers** to support delivery of diabetes management. (p54)", "categories": ["Referral criteria"], "evidence": [{"source": "content.pdf", "page": 54, "text": "54 MANAGING  DIABETES\nBut in many settings, access \nto even the most basic health \nprofessionals with appropriate \ntraining in diabetes management \nis not available. While more \nand better-trained health \nprofessionals could rectify this \nproblem, in many situations it is \nnot a realistic solution. However \nthere are examples of innovative \nsolutions, including up-skilling \navailable health professionals to \ndeliver diabetes care (see Box 10) \nand training lay people to deliver \nprotocol-driven care. WHO PEN \nincludes management protocols \nfor non-medically qualified health-\ncare workers.\n3.3 INTEGr ATED MANAGEMENT \nOf DIABETES AND OTHE r \nCHrONIC HEA lTH CONDITIONS\nDiabetes management should be \nintegrated with management of \nother NCDs, and in some settings \ntuberculosis and HIV/AIDS, to \nimprove equity, efficiency and \noutcomes. Diabetes is frequently \ncomorbid with a range of other \ndiseases and conditions, the \nBOx 9.  r EHABI lITATION fO llOwING DIABETES- rElATED AMP uTATION, TAJ", "score": 0.6217312152856479}, {"source": "content.pdf", "page": 49, "text": "49MANAGING  DIABETES\n3.2 MANAGEMENT Of  DIABETES – \nCOr E COMPONENTS\nPeople with diabetes require \naccess to systematic, ongoing and \norganized care delivered by a team \nof skilled health-care providers. \nOutcomes can be improved at \nthe primary care level with basic \ninterventions involving medication, \nhealth education and counselling, \nand consistent follow-up. This \nsystematic care should include \na periodic review of metabolic \ncontrol and complications, an \nagreed and continually updated \ndiabetes care plan, and access \nto person-centred care provided \nby a multidisciplinary team. New \ntechnologies such as telemedicine \nand mobile phone technology are \nalso increasingly being used and \nhave the potential to reach remote \nareas (see Box 7).\nWhile most treatment and tests \ncan be done at primary care level, \nperiodic referral for specialist \ncare is required, for example, for \ncomprehensive eye examinations, \nlaser and surgical treatment of eye \ncomplications, complex kidney \nfunct", "score": 0.5656228011689197}, {"source": "content.pdf", "page": 61, "text": "tality from NCDs. \nDiabetes management can be \nstrengthened even in low-resource \nsettings through implementation \nof the standards and protocols \nsuch as the WHO PEN package. \nEfforts to improve capacity \nfor diagnosis and treatment of \ndiabetes should be undertaken \nin the context of integrated NCD \nmanagement. At a minimum, \ndiabetes and cardiovascular disease \nmanagement can be integrated. \nIntegrated management of \ndiabetes and TB and/or HIV/AIDS \ncan be considered where there is \nhigh prevalence of these diseases.\nImproving access to essential \nmedicines is a vital aspect \nof achieving universal health \ncoverage and of improving health \nsystems’ capacity to prevent and \nmanage diabetes and other NCDs \n(47). Diabetes has been described \nas a tracer condition for assessing \nhealth system performance (48, \n49) for many reasons: it is well-\ndefined, fairly easy to diagnose, \nand common; and because optimal \nmanagement of diabetes requires \nthe coordinated involvement of a \nvariety of", "score": 0.5526844701512902}, {"source": "content.pdf", "page": 75, "text": "75NATIONAl CAPACIT y f Or P rE vENTION  AND  CONT rOl O f DIABETES : A  SNAPSHOT\nthat kick-start locally appropriate \nimplementation of national \nguidelines need to be explored. \nThese might include periodic \naudits and the involvement of \nprofessional associations and \npatients’ groups.\nThe availability of essential \nmedicines and basic technologies \nin primary health care deserves \nfurther exploration, particularly in \ncountries where basic technologies \nand essential medicines are not \nreported to be generally available.\nGreater investment in data for \nsurveillance and monitoring \nis called for, both through \npopulation-based surveys and \nincremental monitoring of \ndiabetes (4).\nFinally, the NCD CCS findings \npresented in this chapter speak \nloudly that progress towards \ndiabetes prevention and \nmanagement is grossly uneven. \nHbA1c tests, considered the \noptimal tool for monitoring blood \nglucose levels (see Part 3), are \nmostly unavailable in low- and \nmiddle-income countries, but", "score": 0.546739841839793}, {"source": "content.pdf", "page": 7, "text": "back-referral are needed, as patients will need periodic specialist assessment or \ntreatment for complications.\nFor those who are diagnosed with diabetes, a series of cost-effective interventions can improve their \noutcomes, regardless of what type of diabetes they may have. These interventions include blood glucose \ncontrol, through a combination of diet, physical activity and, if necessary, medication; control of blood \npressure and lipids to reduce cardiovascular risk and other complications; and regular screening for damage \nto the eyes, kidneys and feet, to facilitate early treatment. Diabetes management can be strengthened \nthrough the use of standards and protocols.\nEfforts to improve capacity for diagnosis and treatment of diabetes should occur in the context of integrated \nnoncommunicable disease (NCD) management to yield better outcomes. At a minimum, diabetes and \ncardiovascular disease management can be combined. Integrated management of diabetes and tuberculosis \nand/or HI", "score": 0.5465281198704005}]}, "metrics": {"category_jaccard": 0.5, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 2, "notes": "Evidence on p54 directly supports task-sharing approaches (up-skilling health professionals, training lay people, WHO PEN protocols for non-medically qualified workers). Answer closely matches evidence with no clear unsupported claims. However, the question asks workforce/task-sharing approaches; expected categories are Medication protocol guidance and Referral criteria, while the model categorized only Referral criteria and the content is not primarily referral criteria, so category alignment is weak."}, "judge_error": null}
{"id": "Q017", "timestamp_utc": "2025-12-16T06:50:45.565527+00:00", "top_k": 5, "question": "What diabetes complications are highlighted as requiring routine screening or monitoring (examples)?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Examples of diabetes complications highlighted as needing routine screening/monitoring include:\n\n- **Eye damage/diabetic retinopathy (risk of vision loss):** periodic **comprehensive eye examinations** for early detection and timely treatment (e.g., laser photocoagulation) to prevent/delay irreversible vision loss. (p53, p50)  \n- **Kidney damage/diabetic nephropathy:** **measurement of urine protein** to detect early kidney damage and help slow progression toward kidney failure. (p53, p50)  \n- **Foot complications related to neuropathy and impaired blood flow (risk of ulcers, gangrene, amputation):** **regular foot examinations** assessing for neuropathy, impaired blood flow, and skin changes. (p53, p50, p61)", "categories": ["Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.5967133996871371}, {"source": "content.pdf", "page": 53, "text": "ests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSome data indicate that less \ncostly self-monitoring by urine \nglucose measurement could be \nan acceptable alternative when \nblood glucose self-monitoring is \nnot possible (23).\nMEDICATION f Or ASSOCIATED \nCArDIO vASCul Ar DISEASE r ISk \nfACTO rS\nComprehensive reduction of \ncardiovascular disease risk factors, \nincluding the control of blood \npressure and lipids in addition to \nblood glucose, is of vital importance \nin preventing the development of \ncardiovascular disease in diabetes, \nbut also in preventing microvascular \ncomplications. This can be achieved \nwith generic medicines from WHO \nModel list of essential medicines  \n(22) (thiazide diuretic, ACE-inhibitor, \nbeta blockers, statin).\nSCr EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress o", "score": 0.5775119113064542}, {"source": "content.pdf", "page": 61, "text": "pids \nto reduce cardiovascular risk and \nother complications; and regular \nscreening and early intervention \nfor damage to the eyes, kidneys \nand feet. This set of interventions \nappears simple but carrying them \nout depends on appropriate \nstructures for health-care delivery \nsuch as access to essential \nmedicines and technologies, \nprotocols for management in \nprimary care, appropriate training \nof health-care providers, referral \nsystems involving specialists, \nand the active participation and \nmotivation of the patient.\nCurrently, primary health-care \nservices in many countries do not \nhave the capacity to diagnose \nand manage diabetes (see Part 4). \nBuilding this capacity is a priority \nto achieve better outcomes for \npeople with diabetes, and to meet \nglobal targets to halt the rise in \nobesity and diabetes and reduce \npremature mortality from NCDs. \nDiabetes management can be \nstrengthened even in low-resource \nsettings through implementation \nof the standards and protocols \nsuc", "score": 0.5527454444931623}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.5472932414985688}, {"source": "content.pdf", "page": 30, "text": "30 Gl OBA l B ur DEN  Of DIABETES\n1.3 BurDEN AND T rENDS IN THE \nCOMP lICATIONS Of  DIABETES\nDiabetes, if not well controlled, \nmay cause blindness, kidney failure, \nlower limb amputation and several \nother long-term consequences that \nimpact significantly on quality of \nlife. There are no global estimates \nof diabetes-related end-stage renal \ndisease, cardiovascular events, \nlower-extremity amputations or \npregnancy complications, though \nthese conditions affect many \npeople living with diabetes. Where \ndata are available – mostly from \nhigh-income countries – prevalence, \nincidence and trends vary hugely \nbetween countries (18, 19).\nlOSS O f v ISION\nDiabetic retinopathy caused \n1.9% of moderate or severe \nvisual impairment globally and \n2.6% of blindness in 2010 (20) . \nStudies suggest that prevalence \nof any retinopathy in persons with \ndiabetes is 35% while proliferative \n(vision-threatening) retinopathy \nis 7% (21). However, retinopathy \nrates are higher among: people \nwith type", "score": 0.5454028111180154}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 5, "notes": "Evidence supports routine screening/monitoring for eyes (periodic comprehensive eye exams), kidneys (urine protein), and feet (regular screening for damage to eyes/kidneys/feet). Answer is mostly grounded, but adds extra specifics not in evidence: neuropathy/impaired blood flow details for foot exam, \"gangrene,\" and implies treatment details beyond cited lines; laser photocoagulation is supported on p53."}, "judge_error": null}
{"id": "Q018", "timestamp_utc": "2025-12-16T06:50:55.223748+00:00", "top_k": 5, "question": "What is recommended regarding periodic comprehensive eye examinations for people with diabetes?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "People with diabetes **should have periodic, comprehensive eye examinations** as part of routine care to support **early detection and treatment of complications** (p53). National diabetes management protocols should include **regular exams for early detection of complications**, specifically **comprehensive eye examination** (p50).\n\nA **comprehensive eye examination** includes **visual acuity testing, intraocular pressure measurement, and a dilated examination of the retina and optic nerve head**, with **retinal imaging strongly recommended** (p50). Periodic **referral for specialist care may be required** to provide comprehensive eye examinations and related treatments (p49).", "categories": ["Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 50, "text": "Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve head, with retinal imaging \nstrongly recommended.\nBOx 7. IMP rOvING DIABETES MANAGEMENT u SING MOBI lE TECHNOl OGy\nSMS-based programmes can contribute to the prevention and management of diabetes in a way \nthat is acceptable to patients and the general population. Interventions studied span the disease \nspectrum, using one-way and two-way SMS messages to provide information, medication reminders, \nand increase patient-provider communication.\nReviews of existing clinical studies indicate that text messaging can be effective in promoting positive \nhealth behaviour change and disease management for people with diabetes (10). When properly designed, \nmobile diabetes support has generated a statistically significant improvement in areas such as patient \nglycaemic control in the short-term and long-term (over 6 months), and medication adherence", "score": 0.5240478695449527}, {"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.48559045076784635}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.47661162818973835}, {"source": "content.pdf", "page": 49, "text": "49MANAGING  DIABETES\n3.2 MANAGEMENT Of  DIABETES – \nCOr E COMPONENTS\nPeople with diabetes require \naccess to systematic, ongoing and \norganized care delivered by a team \nof skilled health-care providers. \nOutcomes can be improved at \nthe primary care level with basic \ninterventions involving medication, \nhealth education and counselling, \nand consistent follow-up. This \nsystematic care should include \na periodic review of metabolic \ncontrol and complications, an \nagreed and continually updated \ndiabetes care plan, and access \nto person-centred care provided \nby a multidisciplinary team. New \ntechnologies such as telemedicine \nand mobile phone technology are \nalso increasingly being used and \nhave the potential to reach remote \nareas (see Box 7).\nWhile most treatment and tests \ncan be done at primary care level, \nperiodic referral for specialist \ncare is required, for example, for \ncomprehensive eye examinations, \nlaser and surgical treatment of eye \ncomplications, complex kidney \nfunct", "score": 0.4381943288421708}, {"source": "content.pdf", "page": 30, "text": "30 Gl OBA l B ur DEN  Of DIABETES\n1.3 BurDEN AND T rENDS IN THE \nCOMP lICATIONS Of  DIABETES\nDiabetes, if not well controlled, \nmay cause blindness, kidney failure, \nlower limb amputation and several \nother long-term consequences that \nimpact significantly on quality of \nlife. There are no global estimates \nof diabetes-related end-stage renal \ndisease, cardiovascular events, \nlower-extremity amputations or \npregnancy complications, though \nthese conditions affect many \npeople living with diabetes. Where \ndata are available – mostly from \nhigh-income countries – prevalence, \nincidence and trends vary hugely \nbetween countries (18, 19).\nlOSS O f v ISION\nDiabetic retinopathy caused \n1.9% of moderate or severe \nvisual impairment globally and \n2.6% of blindness in 2010 (20) . \nStudies suggest that prevalence \nof any retinopathy in persons with \ndiabetes is 35% while proliferative \n(vision-threatening) retinopathy \nis 7% (21). However, retinopathy \nrates are higher among: people \nwith type", "score": 0.4306771328321851}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 5, "notes": "Retrieval is relevant: evidence explicitly states people with diabetes should have periodic comprehensive eye examinations (p53) and guidelines should include regular exams incl. comprehensive eye exam (p50), plus exam components (p50). Groundedness mostly good, but the answer adds unsupported elements: 'early detection and treatment of complications' is broadly consistent with surrounding heading but not explicitly tied to eye exams beyond slowing complications; 'retinal imaging strongly recommended' is supported; 'periodic referral for specialist care may be required' is not supported by the provided p49 excerpt (it mentions multidisciplinary team and systematic care, not specialist referral). Category alignment is correct with 'Complication screening schedules.'"}, "judge_error": null}
{"id": "Q019", "timestamp_utc": "2025-12-16T06:51:05.185511+00:00", "top_k": 5, "question": "What intervention is mentioned for preventing or delaying vision loss from diabetic retinopathy (high level)?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Timely **laser photocoagulation** and **good control of blood glucose** are mentioned as interventions that can **prevent or delay irreversible vision loss** from diabetic retinopathy. People with diabetes should also have **periodic, comprehensive eye examinations** for early detection. (p53)", "categories": ["Medication protocol guidance", "Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.613387569653876}, {"source": "content.pdf", "page": 50, "text": "Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve head, with retinal imaging \nstrongly recommended.\nBOx 7. IMP rOvING DIABETES MANAGEMENT u SING MOBI lE TECHNOl OGy\nSMS-based programmes can contribute to the prevention and management of diabetes in a way \nthat is acceptable to patients and the general population. Interventions studied span the disease \nspectrum, using one-way and two-way SMS messages to provide information, medication reminders, \nand increase patient-provider communication.\nReviews of existing clinical studies indicate that text messaging can be effective in promoting positive \nhealth behaviour change and disease management for people with diabetes (10). When properly designed, \nmobile diabetes support has generated a statistically significant improvement in areas such as patient \nglycaemic control in the short-term and long-term (over 6 months), and medication adherence", "score": 0.5546811844986638}, {"source": "content.pdf", "page": 61, "text": "pids \nto reduce cardiovascular risk and \nother complications; and regular \nscreening and early intervention \nfor damage to the eyes, kidneys \nand feet. This set of interventions \nappears simple but carrying them \nout depends on appropriate \nstructures for health-care delivery \nsuch as access to essential \nmedicines and technologies, \nprotocols for management in \nprimary care, appropriate training \nof health-care providers, referral \nsystems involving specialists, \nand the active participation and \nmotivation of the patient.\nCurrently, primary health-care \nservices in many countries do not \nhave the capacity to diagnose \nand manage diabetes (see Part 4). \nBuilding this capacity is a priority \nto achieve better outcomes for \npeople with diabetes, and to meet \nglobal targets to halt the rise in \nobesity and diabetes and reduce \npremature mortality from NCDs. \nDiabetes management can be \nstrengthened even in low-resource \nsettings through implementation \nof the standards and protocols \nsuc", "score": 0.5539995408158208}, {"source": "content.pdf", "page": 47, "text": "luding life-saving insulin) and technologies is \nworryingly limited in low- and middle-income countries.\nWell-structured health services \ncan provide the key interventions \nand regular follow-up necessary \nto help people with diabetes \nlive long and relatively healthy \nlives, even though it is a chronic, \nprogressive disease. Many of these \ninterventions are known to be \ncost-effective or cost-saving, and \nare feasible even in low-resource \nsettings (1, 2, 3). Controlling blood \nglucose levels and cardiovascular \ndisease risk through counselling \nto promote a healthy diet and \nphysical activity, and through \nuse of medicines, is considered a \n“best buy” for reducing the health \nimpact of NCDs.\nEncouragingly, reductions in the \nrates of several diabetes-related \ncomplications (amputation, \ncardiovascular disease, vision loss, \nend-stage renal disease) have been \nobserved in countries that have \nadequate data to examine trends \nover time (4). Where reductions in \ncomplications have been", "score": 0.5382122764667806}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.5307678350027873}]}, "metrics": {"category_jaccard": 0.5, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 3, "notes": "Retrieval includes the exact statement on p53 about periodic comprehensive eye exams and timely laser photocoagulation plus good glycemic control preventing/delaying irreversible vision loss. Answer is fully supported by evidence. Category alignment is partial: the question expects complication screening schedules; the answer includes screening (periodic eye exams) but also treatment/management interventions (laser photocoagulation, glycemic control), and model_categories include an extra unrelated category (Medication protocol guidance)."}, "judge_error": null}
{"id": "Q020", "timestamp_utc": "2025-12-16T06:51:20.583766+00:00", "top_k": 5, "question": "What test is mentioned to detect early kidney damage in diabetes, and what does early detection enable?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "- **Test mentioned:** **Measurement of urine protein** to reveal **early kidney damage** in people with diabetes (p53).  \n- **What early detection enables:** It enables **early interventions**—specifically, once early kidney damage is detected, **progression to kidney failure can be slowed** using **essential drugs routinely used to treat hypertension** (p53).", "categories": ["Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.5379637103440744}, {"source": "content.pdf", "page": 48, "text": "n (HbA1c), even if the \npatient is not in a fasting state \n(5). HbA1c reflects the average \nblood glucose concentration over \nthe past few weeks, rather than \nthe blood glucose concentration \nat that moment (reflected by \nthe fasting and 2-hour blood \nglucose measurements mentioned \nabove). However, the test is \nmore costly than blood glucose \nmeasurement (5).\nBlood glucose measurement to \ndiagnose diabetes should be \navailable at the primary health-\ncare level. If laboratory analysis \nof venous plasma glucose is not \nfeasible, point-of-care devices that \nmeasure glucose in capillary blood \nand meet current International \nStandardization Organization \n(ISO) standards are an acceptable \nalternative. Unfortunately, testing \ndevices and supplies are often not \navailable where or when necessary – \none survey found the availability of \nblood glucose meters ranged from \n21% to 100% in facilities visited in \nfive developing countries (6).\nEArly DETECTION O f T yPE 2 DIABETES\nWhether people sh", "score": 0.5025579064132718}, {"source": "content.pdf", "page": 48, "text": "lucose meters ranged from \n21% to 100% in facilities visited in \nfive developing countries (6).\nEArly DETECTION O f T yPE 2 DIABETES\nWhether people should be \nscreened or not for type 2 diabetes \nis a much-debated question and \ncurrently there is no definitive \nevidence from randomized trials \nto answer it. Some evidence \nsuggests there are benefits to \nearly detection and treatment, \nlargely because the reduced \nlead time between onset and \ndiagnosis speeds the treatment \nof cardiovascular risk factors – \nparticularly improved management \nof lipids and blood pressure (7).\nThe decision to put in place (or \nnot put in place) systems for \nearly detection is a strategic one \nthat depends on a number of \nfactors. Screening programmes \nwill increase the number of \nclinically diagnosed cases of \ntype 2 diabetes and as such will \nincrease the health-care system \nworkload, not only in dealing with \nthe process of early detection \nbut, more importantly, in dealing \nwith the increased number of", "score": 0.5003641978093274}, {"source": "content.pdf", "page": 47, "text": "nal disease) have been \nobserved in countries that have \nadequate data to examine trends \nover time (4). Where reductions in \ncomplications have been observed \nat population level they are likely \nto be the result of improvements in \nthe management of key risk factors \nsuch as smoking, blood pressure \nand lipid levels, and blood glucose, \nalong with improvements in the \norganization and quality of care.\n3. 1 DIAGNOSIS AND EA rly \nDETECTION\nThe starting point for living well \nwith diabetes is an early diagnosis \n– the longer a person lives with \nundiagnosed and untreated \ndiabetes, the worse the health \noutcomes are likely to be. Easy", "score": 0.4834595098446979}, {"source": "content.pdf", "page": 73, "text": "lar status, and examination \nof the eye with dilated pupil \n(dilated fundus examination). \nIt is clear that these additional \ntechnologies are much more \nreadily available in high-income \ncountries than in low- or middle-\nincome countries.\nMANAGEMENT O f kIDNE y fAIlur E\nDiabetes is a prominent cause of \nkidney disease. Kidney failure, also \ncalled end-stage renal disease, \nrequires renal replacement \ntherapy. Overall, 60% of countries \n(106 countries) reported general \navailability of renal replacement \nfIGurE 12. PErCENTAGE CO uNTrIES r EPOr TING OTHE r TECHNOl OGIES AS GENE rAlly AvAIlABl E IN P uBlICly-fuNDED \nPrIMA ry HEA lTH-CA rE fACI lITIES \nORAL GLUCOSE TOLERANCE TEST HBA1C TEST\nFOOT VASCULAR STATUS BY DOPPLER\nDILATED-PUPIL FUNDUS EXAMINATION\nFOOT VIBRATION PERCEPTION BY TUNING FORK\n% of countries\n60%\n70%\n80%\n90%\n100%\n50%\n40%\n30%\n20%\n10%\n0%\n60%\n70%\n80%\n90%\n100%\n50%\n40%\n30%\n20%\n10%\n0%\nAfrican Region\nRegion of the AmericasEastern Mediterranean \nRegionEuropean Region\nSouth-East A", "score": 0.4770606681272588}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence (p53) explicitly states measurement of urine protein reveals early kidney damage and that early intervention can slow progression to kidney failure using essential antihypertensive drugs. Answer matches and stays within evidence. Category alignment correct (complication screening)."}, "judge_error": null}
{"id": "Q021", "timestamp_utc": "2025-12-16T06:51:27.003208+00:00", "top_k": 5, "question": "What foot-care screening or examination practices are mentioned to reduce risk of ulcers and amputations?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "This question is outside the supported diabetes guideline topics, or no supporting evidence was retrieved.", "categories": [], "evidence": [{"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.5376833562681342}, {"source": "content.pdf", "page": 30, "text": "abetes \nand associated CVD risk factors.\nlOwEr E xTrEMIT y AMP uTATIONS\nDiabetes appears to dramatically \nincrease the risk of lower extremity \namputation because of infected, \nnon-healing foot ulcers (19). Rates \nof amputation in populations with \ndiagnosed diabetes are typically \n10 to 20 times those of non-\ndiabetic populations, and over the \npast decade have ranged from 1.5 \nto 3.5 events per 1000 persons per \nLower limb amputation \nrates are 10 to 20 times \nhigher among people \nwith diabetes", "score": 0.5344696775879059}, {"source": "content.pdf", "page": 30, "text": "vASC ul Ar EvENTS\nAdults with diabetes historically \nhave a two or three times higher \nrate of cardiovascular disease \n(CVD) than adults without diabetes \n(22). The risk of cardiovascular \ndisease increases continuously \nwith rising fasting plasma glucose \nlevels, even before reaching \nlevels sufficient for a diabetes \ndiagnosis (2, 3). The few countries \nin north America, Scandinavia \nand the United Kingdom of Great \nBritain and Northern Ireland that \nhave studied time trends in the \nincidence of cardiovascular events \n(myocardial infarction, stroke \nor CVD mortality) report large \nreductions over the past 20 years \namong people with type 1 or \ntype 2 diabetes (23), although less \nthan the reduction in the non-\ndiabetic population. This decrease \nhas been attributed to reduction \nin the prevalence of smoking and \nbetter management of diabetes \nand associated CVD risk factors.\nlOwEr E xTrEMIT y AMP uTATIONS\nDiabetes appears to dramatically \nincrease the risk of lower extremity \namputa", "score": 0.5087888626567559}, {"source": "content.pdf", "page": 53, "text": "changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational \ntherapy can help minimize the \nimpact of complications on \npeople’s functioning (see Box 9).\nHuMAN r ESO urCES\nA range of health professionals \nis required for the care and \ntreatment of diabetes, including \nphysicians, nurses, dieticians and \nspecialists such as obstetricians, \nophthalmologists, vascular \nsurgeons and physiotherapists.", "score": 0.4864421470029076}, {"source": "content.pdf", "page": 32, "text": "IM, Jones KJ, Thompson MM, et al. Lower extremity \namputations – a review of global variability in incidence. Diabetic Medicine. 2011;28:(10)1144–1153.", "score": 0.4589265831116663}]}, "metrics": {"category_jaccard": 0.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 1, "groundedness": 5, "category_correctness": 1, "notes": "Evidence includes foot-ulcer/amputation risk and a statement that routine foot-care/foot condition changes can prevent ulcers leading to amputation, but it does not actually describe specific screening/exam practices or schedules. The model answered that no supporting evidence was retrieved; that is not fully accurate given some relevant foot-care content was retrieved, though it lacks requested detail. No unsupported claims were made. Category correctness is low because the answer does not address complication screening/examination practices."}, "judge_error": null}
{"id": "Q022", "timestamp_utc": "2025-12-16T06:51:36.701752+00:00", "top_k": 5, "question": "How often should HbA1c be measured in type 2 diabetes, and how does this compare with type 1 diabetes?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "- **Type 2 diabetes:** HbA1c should **ideally be measured twice a year**. (p53)  \n- **Type 1 diabetes:** HbA1c should be measured **more frequently than in type 2 diabetes**, though the evidence provided does **not specify an exact interval**. (p53)", "categories": ["Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 53, "text": "53MANAGING  DIABETES\nmonitoring glycaemic control in \ndiabetes. An advantage of using \nHbA1c is that the patient does not \nneed to be in a fasting state. Ideally \nit should be measured twice a year \nin people with type 2 diabetes \nand more frequently in those with \ntype 1 diabetes. However, HbA1c \ntesting is more costly than glucose \nmeasurement, and therefore less \nreadily available. If HbA1c testing is \nnot available, fasting or post-meal \nblood glucose is an acceptable \nsubstitute.\nSelf-monitoring of blood glucose \nis recommended for patients \nreceiving insulin, and to have a \nplan of action with their health \nprovider on how to adjust insulin \ndosage, food intake and physical \nactivity according to their blood \nglucose levels. Availability of \nself-monitoring devices and strips \nhas not been assessed globally. \nAnecdotal evidence suggests that \nself-monitoring is not available \nfor a vast majority of people on \ninsulin treatment – cost being \ncited as the most frequent reason. \nSom", "score": 0.5588701259243911}, {"source": "content.pdf", "page": 48, "text": "n (HbA1c), even if the \npatient is not in a fasting state \n(5). HbA1c reflects the average \nblood glucose concentration over \nthe past few weeks, rather than \nthe blood glucose concentration \nat that moment (reflected by \nthe fasting and 2-hour blood \nglucose measurements mentioned \nabove). However, the test is \nmore costly than blood glucose \nmeasurement (5).\nBlood glucose measurement to \ndiagnose diabetes should be \navailable at the primary health-\ncare level. If laboratory analysis \nof venous plasma glucose is not \nfeasible, point-of-care devices that \nmeasure glucose in capillary blood \nand meet current International \nStandardization Organization \n(ISO) standards are an acceptable \nalternative. Unfortunately, testing \ndevices and supplies are often not \navailable where or when necessary – \none survey found the availability of \nblood glucose meters ranged from \n21% to 100% in facilities visited in \nfive developing countries (6).\nEArly DETECTION O f T yPE 2 DIABETES\nWhether people sh", "score": 0.5232410744681764}, {"source": "content.pdf", "page": 52, "text": "52 MANAGING  DIABETES\nBlOOD G luCOSE CONT rOl\nThe role of blood glucose control \nin preventing the development \nand progression of complications \nhas been proven in both type 1 \nand type 2 diabetes, with an \nespecially strong relationship \nbetween intensive blood glucose \ncontrol and neuropathy and diabetic \nretinopathy (20, 21). In most patients \nwith diabetes, blood glucose levels \ncan be adequately managed with \nmedicines included in the WHO \nModel list of essential medicines  \n(22). These are metformin, gliclazide, \nand short-acting and intermediate-\nacting human or animal insulin.\nBlood glucose control should \nbe monitored through regular \nmeasurement. People with \ntype 1 diabetes and gestational \ndiabetes need strict control of \nblood glucose which is difficult to \naccomplish and monitor in primary \nhealth care, so they will need more \nfrequent referral to higher levels of \nhealth care.\nGlycated haemoglobin (HbA1c) \nis the method of choice for \nBOx 8. r EvErSING T yPE 2 DIABETES,", "score": 0.4623646729675023}, {"source": "content.pdf", "page": 83, "text": "83ANNE xES\nANNE x A. CurrENT w HO rECOMMENDATIONS f Or THE DIAGNOSTIC C rITE rIA f Or DIABETES AND \nINTEr MEDIATE H yPEr GlyCAEMIA\nIn people who do not have symptoms, a positive test for diabetes should be repeated on another day.  1 \nBlood glucose measurement is relatively simple and cheap and should be available at primary health-care level.\n1. Source: Definition and diagnosis of diabetes and intermediate hyperglycaemia. Geneva: World Health Organization; 2006.\nDiabetes\nFasting plasma glucose\n2-h plasma glucose*\nHbA1c\n≥ 7.0 mmol/L (126 mg/dl)\nor\n≥ 11.1 mmol/L (200 mg/dl)\nor\n≥ 6.5%\nImpaired glucose tolerance (IGT)\nFasting plasma glucose\n2-h plasma glucose*\n< 7.0 mmol/L (126 mg/dl)\nand\n≥ 7.8 and < 11.1 mmol/L\n(140 mg/dl and 200 mg/dl)\nImpaired fasting glucose (IFG)\nFasting plasma glucose\n2-h plasma glucose*\n6.1 to 6.9 mmol/L (110 mg/dl to 125 mg/dl)\nand (if measured)\n< 7.8 mmol/L (140 mg/dl)\nGestational diabetes (GDM)\nOne or more of the following:\nFasting plasma glucose\n1-h plasma gluc", "score": 0.45829332639161646}, {"source": "content.pdf", "page": 26, "text": "4b).\nTyPE 1 DIABETES\nDistinguishing between type  1 \nand type 2 diabetes is not always \neasy as it often requires relatively \nsophisticated laboratory tests for \npancreas function. Distinct global \nestimates of diabetes prevalence \nfor type 1 and type 2 therefore do \nnot exist.\nMuch of our knowledge of the \nincidence of type 1 diabetes \nrelates to children and has been \ngenerated by collaborative \ninitiatives to develop population-\nbased, standardized registries \nof new cases worldwide, such as \nthe WHO DIAMOND Project (5). \nGlobally, these registries recorded \nlarge differences in the incidence \nand prevalence of type 1 diabetes, \nranging from over 60 to under \n0.5  cases annually per 100 000 \nchildren aged under 15 years; \ndifferences in case ascertainment \nfIGurE 4A.  TrENDS IN P rEvAlENCE Of  DIABETES, 1980–2014, B y CO uNTry INCOME G rOuP\n10%\n8%\n6%\n4%\n2%\n0%\n1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014\nPrevalence of diabetes\nLow-income L", "score": 0.44349028087700015}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 5, "notes": "Evidence (p53) explicitly states HbA1c should ideally be measured twice yearly in type 2 diabetes and more frequently in type 1 diabetes without giving a specific interval. The answer matches this exactly and stays within the cited evidence. Category selection aligns with screening/monitoring schedule content."}, "judge_error": null}
{"id": "Q023", "timestamp_utc": "2025-12-16T06:51:45.009538+00:00", "top_k": 5, "question": "What does the report say about early intervention and slowing progression of diabetes complications (general principle)?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "The report states that, while current diabetes treatment does not prevent all complications, **the progression of complications can be slowed by early interventions** (p53). It also emphasizes that **early diagnosis and early detection are critical**, because “the longer a person lives with undiagnosed and untreated diabetes, the worse the health outcomes are likely to be” (p47). In addition, it highlights the importance of **regular screening and early intervention for damage to the eyes, kidneys and feet** as part of diabetes management to reduce complications (p61).", "categories": ["Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.6352521124470136}, {"source": "content.pdf", "page": 47, "text": "nal disease) have been \nobserved in countries that have \nadequate data to examine trends \nover time (4). Where reductions in \ncomplications have been observed \nat population level they are likely \nto be the result of improvements in \nthe management of key risk factors \nsuch as smoking, blood pressure \nand lipid levels, and blood glucose, \nalong with improvements in the \norganization and quality of care.\n3. 1 DIAGNOSIS AND EA rly \nDETECTION\nThe starting point for living well \nwith diabetes is an early diagnosis \n– the longer a person lives with \nundiagnosed and untreated \ndiabetes, the worse the health \noutcomes are likely to be. Easy", "score": 0.6010185608601573}, {"source": "content.pdf", "page": 61, "text": "pids \nto reduce cardiovascular risk and \nother complications; and regular \nscreening and early intervention \nfor damage to the eyes, kidneys \nand feet. This set of interventions \nappears simple but carrying them \nout depends on appropriate \nstructures for health-care delivery \nsuch as access to essential \nmedicines and technologies, \nprotocols for management in \nprimary care, appropriate training \nof health-care providers, referral \nsystems involving specialists, \nand the active participation and \nmotivation of the patient.\nCurrently, primary health-care \nservices in many countries do not \nhave the capacity to diagnose \nand manage diabetes (see Part 4). \nBuilding this capacity is a priority \nto achieve better outcomes for \npeople with diabetes, and to meet \nglobal targets to halt the rise in \nobesity and diabetes and reduce \npremature mortality from NCDs. \nDiabetes management can be \nstrengthened even in low-resource \nsettings through implementation \nof the standards and protocols \nsuc", "score": 0.5875186246051842}, {"source": "content.pdf", "page": 7, "text": "7Ex EC u TI vE  S uMMAry\nPrEvENTING DIABETES\nType 1 diabetes cannot be prevented with current knowledge. Effective approaches are available to prevent \ntype 2 diabetes and to prevent the complications and premature death that can result from all types of \ndiabetes. These include policies and practices across whole populations and within specific settings (school, \nhome, workplace) that contribute to good health for everyone, regardless of whether they have diabetes, such \nas exercising regularly, eating healthily, avoiding smoking, and controlling blood pressure and lipids.\nTaking a life-course perspective is essential for preventing type 2 diabetes, as it is for many health conditions. \nEarly in life, when eating and physical activity habits are formed and when the long-term regulation of energy \nbalance may be programmed, there is a critical window for intervention to mitigate the risk of obesity and \ntype 2 diabetes later in life.\nNo single policy or intervention can ensure this hap", "score": 0.5825369582773672}, {"source": "content.pdf", "page": 40, "text": "activity and \nlead to the loss of excess body \nweight can prevent type 2 diabetes \nin people with impaired glucose \ntolerance, with or without impaired \nfasting glucose. For example, the \nDiabetes Prevention Program \n(DPP) in the USA (30), the Finnish \nDiabetes Prevention Study (DPS) \n(31) and the Chinese Da Qing Study \nshowed that active intervention, \nlasting 2 to 6 years, could have \nextended benefits for glycaemic \nand cardiovascular outcomes that \nlast for 10 to 20 years (32).\nSeveral pharmacological  \ninterventions (for example, \nmetformin and acarbose) have \nalso been shown to prevent or \ndelay type 2 diabetes but, in the \nmajority of studies, this is not as \neffective as changes in diet and \nphysical activity, and the effect \ndissipates after discontinuation \nof the medication (33, 34) .\nKnowledge gained from these \nproof-of-concept studies confirms \nthat type 2 diabetes can be \ndelayed or prevented, but turning \nthis knowledge into large-\nscale impact brings significant \nchall", "score": 0.5807607063105732}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 3, "notes": "Retrieval includes explicit statements supporting early intervention slowing complication progression (p53) and early diagnosis importance (p47), plus screening/early intervention for eyes/kidneys/feet (p61). Answer stays within evidence and accurately paraphrases/cites. However, expected category is 'Complication screening schedules' and the question asks a general principle; the response is more general prevention/early detection than a schedule, so category alignment is only partial."}, "judge_error": null}
{"id": "Q024", "timestamp_utc": "2025-12-16T06:51:52.245675+00:00", "top_k": 5, "question": "What kinds of rehabilitation services are mentioned as helping minimize the impact of diabetes complications?", "expected_categories": ["Complication screening schedules"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "This question is outside the supported diabetes guideline topics, or no supporting evidence was retrieved.", "categories": [], "evidence": [{"source": "content.pdf", "page": 53, "text": "changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational \ntherapy can help minimize the \nimpact of complications on \npeople’s functioning (see Box 9).\nHuMAN r ESO urCES\nA range of health professionals \nis required for the care and \ntreatment of diabetes, including \nphysicians, nurses, dieticians and \nspecialists such as obstetricians, \nophthalmologists, vascular \nsurgeons and physiotherapists.", "score": 0.6642505012616972}, {"source": "content.pdf", "page": 54, "text": "comes (increasing functional independence, \nparticipation in society and continuation of livelihood) in the lives of people with diabetes, knowledge \nof rehabilitation services among the public and all levels of the health-care system remains poor. \nWork is being done to increase the awareness of rehabilitation services and the important role they \nplay in diabetic care.", "score": 0.6329282059761039}, {"source": "content.pdf", "page": 54, "text": "es is frequently \ncomorbid with a range of other \ndiseases and conditions, the \nBOx 9.  r EHABI lITATION fO llOwING DIABETES- rElATED AMP uTATION, TAJI kISTAN\nThe physical complications associated with diabetes, including poor vascularization, can cause lower-\nlimb wounds that may lead to amputation. Without proper care and support this can profoundly limit \na person’s ability to work, play a full family role and enjoy recreational activities. Furthermore, people \nwith diabetic wounds require close attention to prevent infection and deterioration that can lead to \ndeath. Rehabilitation services play a fundamental role across the continuum of care for people with \ndiabetes, helping prevent complications and providing interventions to keep people mobile and active.\nApproximately half of the 5000 people with diabetes that report to Tajikistan’s Republican \nEndocrinology Hospital every year require rehabilitation services. The International Committee of \nthe Red Cross/Special Fund for the", "score": 0.6189176683751612}, {"source": "content.pdf", "page": 54, "text": "n’s Republican \nEndocrinology Hospital every year require rehabilitation services. The International Committee of \nthe Red Cross/Special Fund for the Disabled provides technical support to Tajikistan’s only physical \nrehabilitation centre, which provides multidisciplinary care to people with diabetes and associated \ncomplications.\nThe team of physiotherapists, prosthetists and social workers, provide holistic interventions that \nhelp people work and participate in society. Key aspects of their interventions include:\n y assessment and provision of assistive devices;\n y physical rehabilitation, including strengthening, endurance and gait training for those with lower-\nlimb amputations;\n y facilitating return to work;\n y providing education on self-management to prevent deterioration.\nWhile the rehabilitation service has seen encouraging outcomes (increasing functional independence, \nparticipation in society and continuation of livelihood) in the lives of people with diabetes, knowledge", "score": 0.5908973329246668}, {"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.573570051523646}]}, "metrics": {"category_jaccard": 0.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 5, "category_correctness": 2, "notes": "Evidence explicitly mentions rehabilitation services (physiotherapy and occupational therapy) that help minimize the impact of complications, so the question is supported. The model answer incorrectly states no supporting evidence, but it does not add unsupported clinical claims, so groundedness is high. Expected category is 'Complication screening schedules,' but the question/evidence are about rehabilitation services, not screening; model provided no category, so category correctness is low."}, "judge_error": null}
{"id": "Q025", "timestamp_utc": "2025-12-16T06:52:03.815704+00:00", "top_k": 5, "question": "What is the role of a referral and back-referral system in diabetes care delivery?", "expected_categories": ["Referral criteria"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "A referral and back-referral system supports **integrated, organized diabetes care across levels** by ensuring that:\n\n- **Most routine diabetes management happens at primary care**, with systematic follow-up, medication, education/counselling, and an updated care plan delivered by a multidisciplinary team. **Referral pathways link this ongoing care to higher levels when needed**. (p49, p56)  \n- **Periodic referral to specialists is required for complications and complex care**, such as comprehensive eye examinations and procedures, and complex kidney-related care. (p49)  \n- **Back-referral is needed after specialist input**, because people with diabetes may need periodic specialist assessment/treatment for complications but otherwise require continuing longitudinal management closer to home. (p7)  \n- **Clear referral pathways are part of an organized, integrated health system** and are listed among relatively simple measures (along with standard protocols) to deliver optimal diabetes care. (p56)", "categories": ["Referral criteria"], "evidence": [{"source": "content.pdf", "page": 7, "text": "back-referral are needed, as patients will need periodic specialist assessment or \ntreatment for complications.\nFor those who are diagnosed with diabetes, a series of cost-effective interventions can improve their \noutcomes, regardless of what type of diabetes they may have. These interventions include blood glucose \ncontrol, through a combination of diet, physical activity and, if necessary, medication; control of blood \npressure and lipids to reduce cardiovascular risk and other complications; and regular screening for damage \nto the eyes, kidneys and feet, to facilitate early treatment. Diabetes management can be strengthened \nthrough the use of standards and protocols.\nEfforts to improve capacity for diagnosis and treatment of diabetes should occur in the context of integrated \nnoncommunicable disease (NCD) management to yield better outcomes. At a minimum, diabetes and \ncardiovascular disease management can be combined. Integrated management of diabetes and tuberculosis \nand/or HI", "score": 0.6257675887186406}, {"source": "content.pdf", "page": 70, "text": "eferral of patients from primary \ncare to secondary or tertiary care \nwere reported as available in \n71% of countries (126  countries), \nbut full implementation of such \ncriteria was reported in only 42% \nof countries (74 countries). Full \nimplementation of referral criteria \nis reported as achieved more \noften in upper middle-income \nand high-income countries, but \neven in these categories full \nimplementation is not common \n(54% and 46% respectively).\n126 countries  \nreport having  \na national guideline for \ndiabetes management  \nthat is partially  \nor fully implemented\nfIGurE 9.  PErCENTAGE O f CO uNTrIES r EPOr TING fully  Or  PA rTIA lly IMP lEMENTED DIABETES Gu IDE lINES, B y wHO \nrEGION AND CO uNTry INCOME G rOuP\nFULLY IMPLEMENTED PARTIALLY IMPLEMENTED\n% of countries\n60%\n70%\n80%\n90%\n100%\n50%\n40%\n30%\n20%\n10%\n0%\nLow-income\nAfrican Region\nEuropean Region\nLower middle-incomeRegion of the Americas South-East Asia RegionWestern Pacific RegionEastern Mediterranean \nRegion\nUpper middle-", "score": 0.5472873458965403}, {"source": "content.pdf", "page": 49, "text": "49MANAGING  DIABETES\n3.2 MANAGEMENT Of  DIABETES – \nCOr E COMPONENTS\nPeople with diabetes require \naccess to systematic, ongoing and \norganized care delivered by a team \nof skilled health-care providers. \nOutcomes can be improved at \nthe primary care level with basic \ninterventions involving medication, \nhealth education and counselling, \nand consistent follow-up. This \nsystematic care should include \na periodic review of metabolic \ncontrol and complications, an \nagreed and continually updated \ndiabetes care plan, and access \nto person-centred care provided \nby a multidisciplinary team. New \ntechnologies such as telemedicine \nand mobile phone technology are \nalso increasingly being used and \nhave the potential to reach remote \nareas (see Box 7).\nWhile most treatment and tests \ncan be done at primary care level, \nperiodic referral for specialist \ncare is required, for example, for \ncomprehensive eye examinations, \nlaser and surgical treatment of eye \ncomplications, complex kidney \nfunct", "score": 0.5231736743467348}, {"source": "content.pdf", "page": 56, "text": "56 MANAGING  DIABETES\nexample, includes blood glucose \ncontrol and counselling (for \nhealthy diet and physical activity), \nand, similarly, management of \ndiabetes includes anti-hypertensive \nmedications at lower levels of blood \npressure than for non-diabetics \n(13). An organized and integrated \nhealth system is necessary to \ndeliver optimal diabetes care. \nRelatively simple measures can be \nimplemented, including standard \nprotocols and clear referral \npathways between different \nhealth-care providers and different \nlevels of care.\nA core set of such interventions is \ndefined in the WHO PEN package, \nwhich includes interventions for \ndetection, prevention, treatment \nand care of diabetes, cardiovascular \ndisease, chronic respiratory disease \nand cancer through a primary \nhealth-care approach (13). They are \nevidence-based, cost-effective and \nfeasible for implementation – even \nin low-resource settings. WHO \nPEN equips both physicians and \nnon-physician health workers in \nprimary care", "score": 0.49850206596643803}, {"source": "content.pdf", "page": 57, "text": "57MANAGING  DIABETES\ndiabetes (31), and the National \nTuberculosis Programme was \nsubsequently revised to implement \nthis intervention across India.\nWHO’s Collaborative Framework \nfor Care and Control of Tuberculosis \nand Diabetes provides guidelines \nto establish mechanisms of \ncollaboration, including joint \ncoordination, bi-directional \nsurveillance and screening of \ntuberculosis and type  2 diabetes, \nand guidelines for detection \nand management of diabetes \nin tuberculosis patients (and \nvice versa) (32).\nrEOrIENTING HEA lTH S ySTEMS\nMany health-care systems have \nevolved to respond to acute, infectious \ndisease and are not organized to \nmanage the demographic and \nepidemiogic transition towards \nnoncommunicable diseases. The \npresence of lifelong or long-term \ncomorbidities requires not just a \nrethinking of service delivery but \nalso a reorientation of the entire \nhealth system in order to rise to \nthe challenge of joint management \nof diabetes and other diseases. \nExpanding uni", "score": 0.494107231425791}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 5, "notes": "Retrieval includes multiple excerpts supporting organized care, primary care management, and need for clear referral pathways and back-referral for periodic specialist assessment (pp7,49,56). However, the answer adds specific examples of specialist referrals (e.g., comprehensive eye exams/procedures, complex kidney care) that are not explicitly stated in the provided evidence, reducing groundedness. Category alignment is appropriate for Referral criteria."}, "judge_error": null}
{"id": "Q026", "timestamp_utc": "2025-12-16T06:52:15.198620+00:00", "top_k": 5, "question": "When should primary care consider escalation or referral for ophthalmic evaluation for a person with diabetes?", "expected_categories": ["Referral criteria"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Primary care should consider escalation/referral for ophthalmic evaluation in people with diabetes:\n\n- **Periodically for a comprehensive eye examination**, since this may require specialist care even though most routine management occurs in primary care (p49, p53).  \n- **When comprehensive assessment/treatment is needed**, including **dilated retinal and optic nerve head examination** (with visual acuity and intraocular pressure measurement; retinal imaging strongly recommended) (p50), and for **laser or surgical treatment of eye complications** (p49).  \n\nThe evidence provided does **not** specify exact referral timing intervals (e.g., annually) or symptom-based triggers beyond the need for periodic comprehensive examinations and access to laser/surgical care (p49, p53).", "categories": ["Referral criteria", "Complication screening schedules"], "evidence": [{"source": "content.pdf", "page": 50, "text": "Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve head, with retinal imaging \nstrongly recommended.\nBOx 7. IMP rOvING DIABETES MANAGEMENT u SING MOBI lE TECHNOl OGy\nSMS-based programmes can contribute to the prevention and management of diabetes in a way \nthat is acceptable to patients and the general population. Interventions studied span the disease \nspectrum, using one-way and two-way SMS messages to provide information, medication reminders, \nand increase patient-provider communication.\nReviews of existing clinical studies indicate that text messaging can be effective in promoting positive \nhealth behaviour change and disease management for people with diabetes (10). When properly designed, \nmobile diabetes support has generated a statistically significant improvement in areas such as patient \nglycaemic control in the short-term and long-term (over 6 months), and medication adherence", "score": 0.4846941931987102}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.47872764661500206}, {"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.4745218945534856}, {"source": "content.pdf", "page": 30, "text": "diabetes is 35% while proliferative \n(vision-threatening) retinopathy \nis 7% (21). However, retinopathy \nrates are higher among: people \nwith type  1 diabetes; people \nwith longer duration of diabetes; \nCaucasian populations; and \npossibly among people of lower \nsocioeconomic status (21).\nEND-STAGE r ENA l DISEASE\nPooled data from 54  countries \nshow that at least 80% of cases of \nend-stage renal disease (ESRD) are \ncaused by diabetes, hypertension \nor a combination of the two \n(18). The proportion of ESRD \nattributable to diabetes alone \nranges from 12–55%. The incidence \nof ESRD is up to 10 times as high \nin adults with diabetes as those \nwithout. The prevalence of ESRD \nis heavily dependent on access \nto dialysis and renal replacement \ntherapy – both of which are highly \nvariable between (and in some \ncases within) countries.\nCAr DIO vASC ul Ar EvENTS\nAdults with diabetes historically \nhave a two or three times higher \nrate of cardiovascular disease \n(CVD) than adults without diab", "score": 0.4553172234206303}, {"source": "content.pdf", "page": 49, "text": "49MANAGING  DIABETES\n3.2 MANAGEMENT Of  DIABETES – \nCOr E COMPONENTS\nPeople with diabetes require \naccess to systematic, ongoing and \norganized care delivered by a team \nof skilled health-care providers. \nOutcomes can be improved at \nthe primary care level with basic \ninterventions involving medication, \nhealth education and counselling, \nand consistent follow-up. This \nsystematic care should include \na periodic review of metabolic \ncontrol and complications, an \nagreed and continually updated \ndiabetes care plan, and access \nto person-centred care provided \nby a multidisciplinary team. New \ntechnologies such as telemedicine \nand mobile phone technology are \nalso increasingly being used and \nhave the potential to reach remote \nareas (see Box 7).\nWhile most treatment and tests \ncan be done at primary care level, \nperiodic referral for specialist \ncare is required, for example, for \ncomprehensive eye examinations, \nlaser and surgical treatment of eye \ncomplications, complex kidney \nfunct", "score": 0.4535398061447888}]}, "metrics": {"category_jaccard": 0.5, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 3, "notes": "Evidence supports that people with diabetes should have periodic comprehensive eye examinations and that timely laser photocoagulation can prevent/delay vision loss; comprehensive exam components are listed. However, the answer adds referral/escalation framing (specialist care, routine vs specialist) and includes intraocular pressure measurement and optic nerve head exam as referral triggers without explicit referral criteria in evidence. No exact timing intervals are in evidence; the model appropriately notes this. Categories: includes Referral criteria but also adds Complication screening schedules; evidence more about screening schedule than explicit referral criteria."}, "judge_error": null}
{"id": "Q027", "timestamp_utc": "2025-12-16T06:52:27.651851+00:00", "top_k": 5, "question": "What situations suggest referral or escalation for suspected kidney disease evaluation in diabetes (conceptually)?", "expected_categories": ["Referral criteria"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "Evidence is limited and does not give explicit referral thresholds (e.g., eGFR cutoffs), but it supports escalation/referral for kidney disease evaluation in diabetes conceptually in these situations:\n\n- **Abnormal screening suggesting early kidney damage**: routine screening should include **urine protein measurement**, which “will reveal early kidney damage” and prompts intervention to slow progression (e.g., BP treatment) (p53).  \n- **Progression toward kidney failure / ESRD**: diabetes is a prominent cause of kidney disease, and **kidney failure (end-stage renal disease)** requires **renal replacement therapy** (dialysis or transplant), implying need for specialist-level escalation (p73, p53).  \n- **Need for periodic specialist assessment or treatment for complications**: the document notes that **back-referral/periodic specialist assessment** may be needed because patients may require specialist treatment for complications, which includes kidney damage identified on screening (p7).", "categories": ["Referral criteria"], "evidence": [{"source": "content.pdf", "page": 7, "text": "back-referral are needed, as patients will need periodic specialist assessment or \ntreatment for complications.\nFor those who are diagnosed with diabetes, a series of cost-effective interventions can improve their \noutcomes, regardless of what type of diabetes they may have. These interventions include blood glucose \ncontrol, through a combination of diet, physical activity and, if necessary, medication; control of blood \npressure and lipids to reduce cardiovascular risk and other complications; and regular screening for damage \nto the eyes, kidneys and feet, to facilitate early treatment. Diabetes management can be strengthened \nthrough the use of standards and protocols.\nEfforts to improve capacity for diagnosis and treatment of diabetes should occur in the context of integrated \nnoncommunicable disease (NCD) management to yield better outcomes. At a minimum, diabetes and \ncardiovascular disease management can be combined. Integrated management of diabetes and tuberculosis \nand/or HI", "score": 0.49053004534350164}, {"source": "content.pdf", "page": 30, "text": "diabetes is 35% while proliferative \n(vision-threatening) retinopathy \nis 7% (21). However, retinopathy \nrates are higher among: people \nwith type  1 diabetes; people \nwith longer duration of diabetes; \nCaucasian populations; and \npossibly among people of lower \nsocioeconomic status (21).\nEND-STAGE r ENA l DISEASE\nPooled data from 54  countries \nshow that at least 80% of cases of \nend-stage renal disease (ESRD) are \ncaused by diabetes, hypertension \nor a combination of the two \n(18). The proportion of ESRD \nattributable to diabetes alone \nranges from 12–55%. The incidence \nof ESRD is up to 10 times as high \nin adults with diabetes as those \nwithout. The prevalence of ESRD \nis heavily dependent on access \nto dialysis and renal replacement \ntherapy – both of which are highly \nvariable between (and in some \ncases within) countries.\nCAr DIO vASC ul Ar EvENTS\nAdults with diabetes historically \nhave a two or three times higher \nrate of cardiovascular disease \n(CVD) than adults without diab", "score": 0.4855556693791597}, {"source": "content.pdf", "page": 73, "text": "lar status, and examination \nof the eye with dilated pupil \n(dilated fundus examination). \nIt is clear that these additional \ntechnologies are much more \nreadily available in high-income \ncountries than in low- or middle-\nincome countries.\nMANAGEMENT O f kIDNE y fAIlur E\nDiabetes is a prominent cause of \nkidney disease. Kidney failure, also \ncalled end-stage renal disease, \nrequires renal replacement \ntherapy. Overall, 60% of countries \n(106 countries) reported general \navailability of renal replacement \nfIGurE 12. PErCENTAGE CO uNTrIES r EPOr TING OTHE r TECHNOl OGIES AS GENE rAlly AvAIlABl E IN P uBlICly-fuNDED \nPrIMA ry HEA lTH-CA rE fACI lITIES \nORAL GLUCOSE TOLERANCE TEST HBA1C TEST\nFOOT VASCULAR STATUS BY DOPPLER\nDILATED-PUPIL FUNDUS EXAMINATION\nFOOT VIBRATION PERCEPTION BY TUNING FORK\n% of countries\n60%\n70%\n80%\n90%\n100%\n50%\n40%\n30%\n20%\n10%\n0%\n60%\n70%\n80%\n90%\n100%\n50%\n40%\n30%\n20%\n10%\n0%\nAfrican Region\nRegion of the AmericasEastern Mediterranean \nRegionEuropean Region\nSouth-East A", "score": 0.4714012078513816}, {"source": "content.pdf", "page": 53, "text": "EENING f Or EA rly DETECTION AND \nTrEATMENT Of  COMP lICATIONS\nCurrent treatment of diabetes does \nnot prevent all complications, but \nthe progress of complications can \nbe slowed by early interventions \n(13). People with diabetes should \nhave periodic, comprehensive \neye examinations. Timely laser \nphotocoagulation and good \ncontrol of blood glucose can \nprevent or delay the onset of \nirreversible vision loss, though this \nis not always accessible or available \nin low- and middle-income \ncountries. Measurement of urine \nprotein will reveal early kidney \ndamage, and the progression to \nkidney failure can be slowed by \nessential drugs routinely used to \ntreat hypertension. Kidney failure \nis treated by dialysis or a kidney \ntransplant. Proper footwear and \nregular examination of feet for \nsigns of neuropathy, impaired \nblood flow and skin changes can \nprevent foot ulcers that often lead \nto gangrene and limb amputation. \nRehabilitation services such as \nphysiotherapy and occupational", "score": 0.45526519990702063}, {"source": "content.pdf", "page": 30, "text": "vASC ul Ar EvENTS\nAdults with diabetes historically \nhave a two or three times higher \nrate of cardiovascular disease \n(CVD) than adults without diabetes \n(22). The risk of cardiovascular \ndisease increases continuously \nwith rising fasting plasma glucose \nlevels, even before reaching \nlevels sufficient for a diabetes \ndiagnosis (2, 3). The few countries \nin north America, Scandinavia \nand the United Kingdom of Great \nBritain and Northern Ireland that \nhave studied time trends in the \nincidence of cardiovascular events \n(myocardial infarction, stroke \nor CVD mortality) report large \nreductions over the past 20 years \namong people with type 1 or \ntype 2 diabetes (23), although less \nthan the reduction in the non-\ndiabetic population. This decrease \nhas been attributed to reduction \nin the prevalence of smoking and \nbetter management of diabetes \nand associated CVD risk factors.\nlOwEr E xTrEMIT y AMP uTATIONS\nDiabetes appears to dramatically \nincrease the risk of lower extremity \namputa", "score": 0.44784622438496524}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 4, "groundedness": 3, "category_correctness": 5, "notes": "Evidence supports general concepts: periodic screening for kidney damage (p7, p53) and that urine protein reveals early kidney damage (p53); kidney failure/ESRD requires renal replacement therapy (p73) and diabetes is a major cause of ESRD (p30). However, evidence does not explicitly state referral/escalation criteria; claims like 'prompts intervention' and that screening findings imply referral are interpretive, and p7 mentions specialist assessment for complications generally, not kidney-specific thresholds."}, "judge_error": null}
{"id": "Q028", "timestamp_utc": "2025-12-16T06:52:38.422488+00:00", "top_k": 5, "question": "What does the report say about having standard criteria for referral from primary to secondary/tertiary care?", "expected_categories": ["Referral criteria"], "ok": true, "http_status": 200, "error": null, "response": {"answer": "The report states that **a referral system based on standard criteria helps continuity of care and optimal use of services across levels of care** (primary to secondary/tertiary) (p70). It also notes that **standard referral criteria were reported as available in 71% of countries (126 countries), but fully implemented in only 42% (74 countries)** (p70). Full implementation is **more common in upper-middle and high-income countries**, but still **not common even there** (54% and 46% respectively) (p70).", "categories": ["Referral criteria"], "evidence": [{"source": "content.pdf", "page": 70, "text": "eferral of patients from primary \ncare to secondary or tertiary care \nwere reported as available in \n71% of countries (126  countries), \nbut full implementation of such \ncriteria was reported in only 42% \nof countries (74 countries). Full \nimplementation of referral criteria \nis reported as achieved more \noften in upper middle-income \nand high-income countries, but \neven in these categories full \nimplementation is not common \n(54% and 46% respectively).\n126 countries  \nreport having  \na national guideline for \ndiabetes management  \nthat is partially  \nor fully implemented\nfIGurE 9.  PErCENTAGE O f CO uNTrIES r EPOr TING fully  Or  PA rTIA lly IMP lEMENTED DIABETES Gu IDE lINES, B y wHO \nrEGION AND CO uNTry INCOME G rOuP\nFULLY IMPLEMENTED PARTIALLY IMPLEMENTED\n% of countries\n60%\n70%\n80%\n90%\n100%\n50%\n40%\n30%\n20%\n10%\n0%\nLow-income\nAfrican Region\nEuropean Region\nLower middle-incomeRegion of the Americas South-East Asia RegionWestern Pacific RegionEastern Mediterranean \nRegion\nUpper middle-", "score": 0.581694441766158}, {"source": "content.pdf", "page": 70, "text": "70 NATIONAl CAPACIT y f Or P rE vENTION  AND  CONT rOl O f DIABETES : A  SNAPSHOT\n(126 countries) report having a \nnational guideline for diabetes \nmanagement that is either fully or \npartially implemented. Less than \nhalf of countries (47%) report full \nimplementation. Middle- and high-\nincome countries were more likely \nto report implementing guidelines \nfor managing diabetes, with more \nthan 70% reporting full or partial \nimplementation (see Figure  9). \nLess than half (46%) of low-\nincome countries reported fully or \npartially implementing diabetes \nmanagement guidelines.\nDiabetes management happens \nat different levels of the health-\ncare delivery system. A referral \nsystem based on standard criteria \ncontributes to continuity of care \nand ensures the optimal use of \nhealth-care services at different \nlevels. Standard criteria for \nreferral of patients from primary \ncare to secondary or tertiary care \nwere reported as available in \n71% of countries (126  countries), \nbut full impl", "score": 0.4401926521648674}, {"source": "content.pdf", "page": 7, "text": "back-referral are needed, as patients will need periodic specialist assessment or \ntreatment for complications.\nFor those who are diagnosed with diabetes, a series of cost-effective interventions can improve their \noutcomes, regardless of what type of diabetes they may have. These interventions include blood glucose \ncontrol, through a combination of diet, physical activity and, if necessary, medication; control of blood \npressure and lipids to reduce cardiovascular risk and other complications; and regular screening for damage \nto the eyes, kidneys and feet, to facilitate early treatment. Diabetes management can be strengthened \nthrough the use of standards and protocols.\nEfforts to improve capacity for diagnosis and treatment of diabetes should occur in the context of integrated \nnoncommunicable disease (NCD) management to yield better outcomes. At a minimum, diabetes and \ncardiovascular disease management can be combined. Integrated management of diabetes and tuberculosis \nand/or HI", "score": 0.4294294092087577}, {"source": "content.pdf", "page": 41, "text": "gic one specific \nto each health-care setting, and \nwill depend, at least in part, on \nthe numbers likely to be identified \nand the resources available to \nadequately deal with them (see \nalso Chapter 4 for early detection \nof undiagnosed diabetes).\nWhether or not intensive individual \ninterventions are made available, \nand whether or not systematic \nassessment of risk is undertaken, \nprimary health-care services must \nbe equipped to manage people \nwith high risk of type 2 diabetes. \nClinical vigilance alone, even in \nthe absence of systems for early \ndetection of type 2 diabetes or \nsystematic risk prediction, will \nidentify people who are at high", "score": 0.4063479596041306}, {"source": "content.pdf", "page": 48, "text": "alth-care system \nworkload, not only in dealing with \nthe process of early detection \nbut, more importantly, in dealing \nwith the increased number of \nclinically diagnosed cases that will \nbe found (8). No system should be \nestablished without consideration \nof whether local health-care \nresources are sufficient to cope \nwith this extra workload. Simply \nadding new cases to a health-\ncare system without additional \ninvestment will, in the absence of \ncompensating efficiencies, result in \npoorer average care (9).\nThe longer a \nperson lives with \nundiagnosed and \nuntreated diabetes, \nthe worse their \nhealth outcomes \nare likely to be", "score": 0.3918612439064301}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 5, "groundedness": 4, "category_correctness": 5, "notes": "Evidence on p70 supports availability (71%) and full implementation (42%) of standard referral criteria, and that full implementation is more common in upper-middle/high-income countries but still not common (54%/46%). The answer’s quantitative statements match the evidence. However, the claim that standard referral criteria \"helps continuity of care and optimal use of services\" is only partially supported: evidence mentions a referral system based on standard criteria (text is truncated after \"based on sta…\") but does not explicitly state the continuity/optimal use rationale in the provided excerpts."}, "judge_error": null}
{"id": "Q029", "timestamp_utc": "2025-12-16T06:52:44.929097+00:00", "top_k": 5, "question": "How do I cook pasta al dente?", "expected_categories": [], "ok": true, "http_status": 200, "error": null, "response": {"answer": "This question is outside the supported diabetes guideline topics, or no supporting evidence was retrieved.", "categories": [], "evidence": [{"source": "content.pdf", "page": 46, "text": "PArT 3\nMANAGING DIABETES", "score": 0.10557413505840417}, {"source": "content.pdf", "page": 34, "text": "PrEvENTING DIABETES\nPArT 2", "score": 0.09472280261599017}, {"source": "content.pdf", "page": 52, "text": "y. Participants consumed \na predominantly liquid diet consisting of four portions a day, each of 190 calories. Participants were \nalso encouraged to eat low-carbohydrate, high-fibre vegetables.\nBy week 8, average weight loss was 10 kg. Several people saw improvements in blood glucose levels \nand in blood pressure. Three months after finishing the 8-week diet, 17 participants had fasting \nplasma glucose (FPG) below the diagnostic threshold for diabetes compared to three at the start, \nand despite remaining off glucose-lowering medication. For nine of the 12 participants on medication \nfor hypertension at the start of the study, blood pressure fell sufficiently that they could stop taking \nhypertension medication by the 8th week.\nParticipants have so far articulated several challenges in participating in the study, including the monotony \nof the low-calorie diet phase, the high cost of fresh fruits and vegetables, and feeling poorly equipped to \nprepare non-starchy vegetables, even with", "score": 0.0928587171283857}, {"source": "content.pdf", "page": 18, "text": "et. \n2015;386(10010):2287–323.\n5. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist circumference \nand waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiologic Reviews. \n2007;29:115 –28.\n6. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:(9712)408–418.\n7. Ley SH, Hamdy, O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary \ncomponents and nutritional strategies. Lancet. 2014;383(9933):1999–2007.\n8. Fats and fatty acids in human nutrition: report of an expert consultation. FAO Food and Nutrition Paper \n91. Rome: Food and Agriculture Organization of the United Nations; 2010.\n9. Diet, nutrition and the prevention of chronic diseases: report of a Joint WHO/FAO Expert Consultation. \nWHO Technical Report Series, No. 916. Geneva: World Health Organization; 2003.\n10. WHO Guideline: sugars intake in adults and children. Geneva: World Health Organization; 2015.\n11. Te Morenga L, Mallard S, Mann", "score": 0.09090515740014422}, {"source": "content.pdf", "page": 50, "text": "50 MANAGING  DIABETES\nNational guidelines and management \nprotocols developed for (or adapted \nto) individual settings are useful \ntools in achieving a standardized and \nconsistent management approach. \nThey should cover these basic \nprinciples of diabetes management:\n y Interventions to promote and \nsupport healthy lifestyles, \nincluding healthy diet, physical \nactivity, avoidance of tobacco \nuse and harmful use of alcohol.\n y Medication for blood glucose \ncontrol – insulin or oral hypo-\nglycaemic agents as required.\n y Medication to control cardio-\nvascular disease risk.\n y Regular exams for early detection \nof complications: comprehensive \neye examination  1, measurement \nof urine protein, and assessment \nof feet for signs of neuropathy.\n y Standard criteria for referral of \npatients from primary care to \nsecondary or tertiary care.\n1. Comprehensive eye examination \nincludes visual acuity, intraocular \npressure measurement and dilated \nexamination of the retina and the \noptic nerve", "score": 0.08603477634841805}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 0, "groundedness": 5, "category_correctness": 5, "notes": "Question is about cooking pasta al dente; retrieved evidence is generic diabetes guideline headings and content unrelated to pasta cooking. Answer appropriately declines as out of scope; no clinical claims made. Categories are empty and align with expected (none)."}, "judge_error": null}
{"id": "Q030", "timestamp_utc": "2025-12-16T06:52:51.452815+00:00", "top_k": 5, "question": "What are the best strength training plans for marathon runners without diabetes?", "expected_categories": [], "ok": true, "http_status": 200, "error": null, "response": {"answer": "This question is outside the supported diabetes guideline topics, or no supporting evidence was retrieved.", "categories": [], "evidence": [{"source": "content.pdf", "page": 51, "text": "have a beneficial effect on insulin \naction, blood glucose control \nand metabolic abnormalities \nassociated with diabetes. Physical \nactivity can also be beneficial in \nreducing cardiovascular disease \nrisk factors. Activity should be \nregular and ideally combine \naerobic exercise with resistance \ntraining (19).\nBlood glucose control \nis important in \npreventing and slowing \nthe progression of \ncomplications", "score": 0.4088740294518761}, {"source": "content.pdf", "page": 45, "text": "a P , Keinanen-Kiukaanniemi, et al. Ten-year \nmortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study – secondary analysis of \nthe randomized trial. PLoS.One. 2009;4:(5)e5656.\n32. Li G, Zhang P , Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions \nto prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. \n2008;371:(9626)1783–1789.\n33. Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-\nanalysis of different intervention strategies. Diabetes, Obesity and Metabolism. 2014;16:(8)719–727.\n34. Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roque IF, Richter B, Mauricio D. Exercise or exercise \nand diet for preventing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. \n2008;(3):CD003054.\n35. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. \nDiabetes Care. 2003;26:(3)725–731.", "score": 0.4070914309606535}, {"source": "content.pdf", "page": 40, "text": "activity and \nlead to the loss of excess body \nweight can prevent type 2 diabetes \nin people with impaired glucose \ntolerance, with or without impaired \nfasting glucose. For example, the \nDiabetes Prevention Program \n(DPP) in the USA (30), the Finnish \nDiabetes Prevention Study (DPS) \n(31) and the Chinese Da Qing Study \nshowed that active intervention, \nlasting 2 to 6 years, could have \nextended benefits for glycaemic \nand cardiovascular outcomes that \nlast for 10 to 20 years (32).\nSeveral pharmacological  \ninterventions (for example, \nmetformin and acarbose) have \nalso been shown to prevent or \ndelay type 2 diabetes but, in the \nmajority of studies, this is not as \neffective as changes in diet and \nphysical activity, and the effect \ndissipates after discontinuation \nof the medication (33, 34) .\nKnowledge gained from these \nproof-of-concept studies confirms \nthat type 2 diabetes can be \ndelayed or prevented, but turning \nthis knowledge into large-\nscale impact brings significant \nchall", "score": 0.37965920162581734}, {"source": "content.pdf", "page": 79, "text": "ramework \nConvention on Tobacco Control.\n4. ST rENGTHEN AND Or IENT HEA lTH S ySTEMS TO ADD rESS DIABETES\nImprovements in diabetes management will reduce rates of complications, ease pressure on health systems \nand improve quality of life for people living with diabetes.\nThe core components of diabetes management include diagnosis; health education and counselling to promote \nhealthy choices and self-care; medications in some cases; screening and treatment of complications; and \nconsistent follow-up. Provision of these building blocks of care in a primary health-care setting requires adequate \nhealth infrastructure and planning.\nDiabetes management should be part of national NCD management and be incorporated into the package \nof essential services included in universal health coverage. Recommended actions to strengthen diabetes \nmanagement include the following steps.\n y Adapt and implement a primary health-care package for the diagnosis and effective management of all \ntypes of diabe", "score": 0.377182964619763}, {"source": "content.pdf", "page": 51, "text": "51MANAGING  DIABETES\n y Integrated management of \ndiabetes and other diseases \n(see Diabetes and other NCDs,  \npage  55).\nThe effectiveness of diabetes \nmanagement ultimately depends \non people’s compliance with \nrecommendations and treatment. \nPatient education is therefore \nan important component of \ndiabetes management. Patients \nneed to understand the principles \nand importance of a healthy \ndiet, adequate physical activity, \navoidance of tobacco and harmful \nuse of alcohol, adherence to \nmedication, foot hygiene and \nappropriate footwear, and the \nneed for periodic assessment \nof metabolic control and the \npresence or progression of \ncomplications (13).\nINTE rvENTIONS TO P rOMOTE \nHEA lTHIE r EATING AND PH ySICA l \nACTI vIT y\nAll people with diabetes need \ncounselling on healthy diet and \nregular physical activity, adapted \nto their capabilities. Existing \nguidelines for dietary management \nof type 2 diabetes do not give \nidentical recommendations, \nbut all agree on: a lower calor", "score": 0.3703023525845269}]}, "metrics": {"category_jaccard": 1.0, "evidence_nonempty": true}, "judge": {"retrieval_relevance": 2, "groundedness": 5, "category_correctness": 5, "notes": "Evidence discusses physical activity combining aerobic and resistance training in the context of diabetes management/prevention, not strength plans for marathon runners without diabetes. The system answer states topic is outside supported diabetes guidelines or no evidence retrieved; this is mostly consistent with evidence not addressing the user’s need, though evidence was retrieved (so the 'no supporting evidence was retrieved' clause is only partially accurate). No unsupported clinical claims were made. No categories were applied; since the question is out of scope for the provided allowed diabetes categories, category alignment is acceptable."}, "judge_error": null}
